<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genet</journal-id><journal-title>BMC Genetics</journal-title><issn pub-type="epub">1471-2156</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2156-8-68</article-id><article-id pub-id-type="pmid">17916242</article-id><article-id pub-id-type="doi">10.1186/1471-2156-8-68</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The <italic>BRCA1 </italic>Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Pereira</surname><given-names>Lut&#x000e9;cia H Mateus</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>luteciap@hotmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Pineda</surname><given-names>Marbin A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>pinedama@mail.nih.gov</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Rowe</surname><given-names>William H</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rowew@mail.nih.gov</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Fonseca</surname><given-names>Libia R</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>lcaba003@fiu.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Greene</surname><given-names>Mark H</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>greenem@mail.nih.gov</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Offit</surname><given-names>Kenneth</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>offitk@mskcc.org</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Ellis</surname><given-names>Nathan A</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>naellis@uchicago.edu</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Zhang</surname><given-names>Jinghui</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jinghuiz@mail.nih.gov</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Collins</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>A.R.Collins@soton.ac.uk</email></contrib><contrib id="A10" corresp="yes" contrib-type="author"><name><surname>Struewing</surname><given-names>Jeffery P</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>struewij@mail.nih.gov</email></contrib></contrib-group><aff id="I1"><label>1</label>Laboratory of Population Genetics, National Cancer Institute, Bethesda, MD 20892, USA</aff><aff id="I2"><label>2</label>Department of Biological Sciences, Florida International University, University Park, Miami, FL 33199, USA</aff><aff id="I3"><label>3</label>Clinical Genetics Branch, National Cancer Institute, Bethesda, MD 20892, USA</aff><aff id="I4"><label>4</label>Memorial Sloan Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY 10021, USA</aff><aff id="I5"><label>5</label>Gastroenterology Section, Department of Medicine, University of Chicago, Chicago, IL 60637, USA</aff><aff id="I6"><label>6</label>Human Genetics Division, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>4</day><month>10</month><year>2007</year></pub-date><volume>8</volume><fpage>68</fpage><lpage>68</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2156/8/68"/><history><date date-type="received"><day>4</day><month>12</month><year>2006</year></date><date date-type="accepted"><day>4</day><month>10</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Pereira et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Pereira et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Pereira H Mateus Lut&#x000e9;cia luteciap@hotmail.com </dc:author><dc:title> The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Genetics 8(1): 68-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2156(2007)8:1&#x0003c;68&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2156</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>We studied linkage disequilibrium (LD) patterns at the <italic>BRCA1 </italic>locus, a susceptibility gene for breast and ovarian cancer, using a dense set of 114 single nucleotide polymorphisms in 5 population groups. We focused on Ashkenazi Jews in whom there are known founder mutations, to address the question of whether we would have been able to identify the 185delAG mutation in a case-control association study (should one have been done) using anonymous genetic markers. This mutation is present in approximately 1% of the general Ashkenazi population and 4% of Ashkenazi breast cancer cases. We evaluated LD using pairwise and haplotype-based methods, and assessed correlation of SNPs with the founder mutations using Pearson's correlation coefficient.</p></sec><sec><title>Results</title><p><italic>BRCA1 </italic>is characterized by very high linkage disequilibrium in all populations spanning several hundred kilobases. Overall, haplotype blocks and pair-wise LD bins were highly correlated, with lower LD in African <italic>versus </italic>non-African populations. The 185delAG and 5382insC founder mutations occur on the two most common haplotypes among Ashkenazim. Because these mutations are rare, even though they are in strong LD with many other SNPs in the region as measured by D-prime, there were no strong associations when assessed by Pearson's correlation coefficient, <italic>r </italic>(maximum of 0.04 for the 185delAG).</p></sec><sec><title>Conclusion</title><p>Since the required sample size is related to the inverse of <italic>r</italic>, this suggests that it would have been difficult to map <italic>BRCA1 </italic>in an Ashkenazi case-unrelated control association study using anonymous markers that were linked to the founder mutations.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Numerous advances in our understanding of genetic susceptibility to breast cancer have been made over the past decade, most notably the discovery of <italic>BRCA1 </italic>in 1994 and <italic>BRCA2 </italic>in 1995 [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Mutations in these genes account for approximately 2/3 of families with clearly inherited forms of breast and ovarian cancer (5 or more cases in a family) [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. In addition to the high-penetrance genes <italic>BRCA1/BRCA2</italic>, rare mutations in a number of other genes, such as <italic>CHEK2</italic>, <italic>ATM</italic>, <italic>BRIP1</italic>, and <italic>PALB1 </italic>predispose to breast cancer [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B9">9</xref>], as do more common variants in <italic>CASP8 </italic>and <italic>TGFB1</italic>[<xref ref-type="bibr" rid="B10">10</xref>]. The total heritability of breast cancer is at least 10% [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], and possibly up to 25% or higher [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Mutations in known high-risk genes, however, account for a relatively small proportion (probably less than 20%) of the excess risk due to genetic factors [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Fueled by the completion of the first phases of the HapMap project [<xref ref-type="bibr" rid="B17">17</xref>], which characterized common variation within the genome of four population groups, there is considerable interest in using these resources to map susceptibility genes for common, complex diseases. The genome-wide case-control association study, whereby the prevalence of genetic variants is compared between cases and unrelated control subjects without the disease, may have the greatest power to identify novel susceptibility genes [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. They rely on using a very dense set of markers that capture a significant fraction of all common genetic variation, such that the variants assayed either include those that are biologically relevant, or those which are highly-correlated with the former due to linkage disequilibrium. Although some design and analysis issues remain, numerous common variants have now been identified for breast cancer and other conditions using this design [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Breast cancer may serve as a useful paradigm for common, complex disease mapping studies because, while a portion of susceptibility genes have been identified, the majority of the residual familial clustering remains unexplained, and is likely to be polygenic in nature, due to a number of lower-penetrance genes in the context of environmental exposures [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Furthermore, there are two common Ashkenazi Jewish (AJ) founder <italic>BRCA1 </italic>mutations, 185delAG and 5382insC, initially identified in linkage studies of multiple-case breast/ovarian cancer families [<xref ref-type="bibr" rid="B25">25</xref>]. This contrasts with most other populations in which there are numerous unique <italic>BRCA1/BRCA2 </italic>mutations, with none present at 1% or greater population frequency. The <italic>BRCA1 </italic>AJ founder mutations account for the majority of Jewish breast-ovarian cancer families, and are present in approximately 1% of the general Jewish population [<xref ref-type="bibr" rid="B26">26</xref>]. The AJ founder mutations, owing to their high prevalence compared to other populations, offered an opportunity to test whether they might have been identified through a case-control association study of the kind suggested as the new gene discovery strategy in the post-HapMap era.</p></sec><sec><title>Results</title><sec><title>SNP allele frequencies</title><p>A total of 289 unrelated reference subjects selected without regard to breast cancer from five population groups (48 each from African-Americans, Chinese-Americans and Mexican-Americans, 60 CEPH subjects, and 85 Ashkenazi Jews) were genotyped across <italic>BRCA1</italic>, spanning a region of approximately 646 kb. Table <xref ref-type="table" rid="T1">1</xref> presents the allele frequencies and Hardy-Weinberg <italic>P</italic>-vales for all the 112 polymorphic SNPs and the two founder mutations that were typed for all 5 populations. Eight of 570 tests showed departures from equilibrium at the 0.01 level, but because none of the eight showed Mendelian segregation errors within families, and because of the number of comparisons performed, they were not excluded from later calculations. Allele frequencies were generally highly correlated among Ashkenazi Jews, CEPH, Chinese-Americans and Mexican-Americans (minimum <italic>r </italic>&#x0003e;0.82), whereas African-Americans presented the lowest correlation values with all the other populations (maximum <italic>r </italic>&#x0003c;0.44). The highest correlation was found between Ashkenazi Jews and CEPH (<italic>r </italic>= 0.947) and the lowest between African-Americans and Mexican-Americans (<italic>r </italic>= 0.362). Most of the private SNPs (<italic>n </italic>= 18) originated in the African-American samples, although private SNPs were also observed in Ashkenazi Jews (<italic>n </italic>= 4), Chinese-Americans (<italic>n </italic>= 3), and Mexican-Americans (<italic>n </italic>= 1) (Table <xref ref-type="table" rid="T1">1</xref>). Total observed heterozygosity for each marker across the five populations ranged from 0.4% for private SNPs to 49.3% [see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>]. F<sub>ST </sub>ranged from 0.0047 (SNP8 &#x02013; rs8176072) to 0.4338 (SNP102 &#x02013; rs2593595). Sixty three percent of the SNPs showed little genetic differentiation (F<sub>ST </sub>&#x0003c; 0.05), followed by twenty eight percent with moderate (0.05&#x02013;0.15) and less than ten percent with higher genetic differentiation. We also calculated pair-wise F<sub>ST </sub>measures, and the distribution was very similar for the Ashkenazi Jews, CEPH, Chinese-Americans and Mexican-Americans <italic>versus </italic>each other (range from 0.008&#x02013;0.018) as compared with African-Americans <italic>versus </italic>all the other populations (range from 0.082&#x02013;0.092), showing that African-Americans had by far the greatest level of differentiation. These results are congruent with the low allele frequency correlation values observed between African-Americans <italic>versus </italic>all the other groups.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>SNP Frequencies and Hardy-Weinberg P-Values</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center" colspan="2">Ashkenazi Jews (n = 85)</td><td align="center" colspan="2">CEPH (n = 60)</td><td align="center" colspan="2">African Americans (n = 48)</td><td align="center" colspan="2">Chinese Americans (n = 48)</td><td align="center" colspan="2">Mexican Americans (n = 48)</td></tr><tr><td align="left">rs number</td><td align="center">SNP Number</td><td align="center">SNP name</td><td align="center">Position b33<sup>a</sup></td><td align="center">Position b36.1<sup>b</sup></td><td align="center">Com Allele<sup>c</sup></td><td align="center">Min Allele<sup>d</sup></td><td align="center">maf<sup>e</sup></td><td align="center"><italic>P</italic>-value</td><td align="center">maf</td><td align="center"><italic>P</italic>-value</td><td align="center">maf</td><td align="center"><italic>P</italic>-value</td><td align="center">maf</td><td align="center"><italic>P</italic>-value</td><td align="center">maf</td><td align="center"><italic>P</italic>-value</td></tr></thead><tbody><tr><td align="left">13119</td><td align="center">1</td><td align="center">C_9270420</td><td align="center">41373486</td><td align="center">38718247</td><td align="center">c</td><td align="center">t</td><td align="center">0.424</td><td align="center">0.580</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.177</td><td align="center">0.624</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">748620</td><td align="center">2</td><td align="center">C_9270421</td><td align="center">41373037</td><td align="center">38717798</td><td align="center">c</td><td align="center">g</td><td align="center">0.440</td><td align="center">0.640</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.240</td><td align="center">0.550</td><td align="center">0.391</td><td align="center">0.518</td><td align="center">0.465</td><td align="center">0.669</td></tr><tr><td align="left">17599948</td><td align="center">3</td><td align="center">C_9270454</td><td align="center">41364175</td><td align="center">38708936</td><td align="center">a</td><td align="center">g</td><td align="center">0.211</td><td align="center">0.649</td><td align="center">0.192</td><td align="center">0.865</td><td align="center">0.104</td><td align="center">0.022</td><td align="center">0.094</td><td align="center">0.326</td><td align="center">0.362</td><td align="center">0.591</td></tr><tr><td align="left">11653231</td><td align="center">4</td><td align="center">C_95201</td><td align="center">41240225</td><td align="center">38584986</td><td align="center">g</td><td align="center">a</td><td align="center">0.435</td><td align="center">0.703</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.240</td><td align="center">0.550</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.467</td><td align="center">0.905</td></tr><tr><td align="left">9908805</td><td align="center">5</td><td align="center">C_3178692</td><td align="center">41230675</td><td align="center">38575436</td><td align="center">c</td><td align="center">t</td><td></td><td></td><td align="center">0.008</td><td align="center">0.948</td><td align="center">0.375</td><td align="center">0.878</td><td></td><td></td><td align="center">0.011</td><td align="center">0.941</td></tr><tr><td align="left">2175957</td><td align="center">6</td><td align="center">C_11631183</td><td align="center">41195587</td><td align="center">38540348</td><td align="center">t</td><td align="center">g</td><td align="center">0.447</td><td align="center">0.665</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.250</td><td align="center">0.441</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.446</td><td align="center">0.935</td></tr><tr><td align="left">3092986</td><td align="center">7</td><td align="center">BR1_000340</td><td align="center">41186761</td><td align="center">38531522</td><td align="center">a</td><td align="center">g</td><td align="center">0.051</td><td align="center">0.636</td><td align="center">0.042</td><td align="center">0.736</td><td align="center">0.010</td><td align="center">0.942</td><td></td><td></td><td align="center">0.031</td><td align="center">0.823</td></tr><tr><td align="left">8176072</td><td align="center">8</td><td align="center">BR1_000392</td><td align="center">41186709</td><td align="center">38531470</td><td align="center">t</td><td align="center">a</td><td align="center"><underline>0.006<sup>f</sup></underline></td><td align="center">0.957</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176074</td><td align="center">9</td><td align="center">BR1_000571</td><td align="center">41186530</td><td align="center">38531291</td><td align="center">g</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.010</underline></td><td align="center">0.942</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">3765640</td><td align="center">10</td><td align="center">C_2615164</td><td align="center">41185012</td><td align="center">38529773</td><td align="center">a</td><td align="center">g</td><td align="center">0.440</td><td align="center">0.640</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.228</td><td align="center">0.740</td><td align="center">0.394</td><td align="center">0.433</td><td align="center">0.444</td><td align="center">0.592</td></tr><tr><td align="left">NA<sup>g</sup></td><td align="center">11</td><td align="center">M_185delAG</td><td align="center">41184811</td><td align="center">38529572</td><td align="center">a</td><td align="center">-</td><td align="center"><underline>0.006</underline></td><td align="center">0.957</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176090</td><td align="center">12</td><td align="center">BR1_007918</td><td align="center">41179183</td><td align="center">38523944</td><td align="center">c</td><td align="center">g</td><td></td><td></td><td align="center">0.008</td><td align="center">0.948</td><td align="center">0.096</td><td align="center">0.338</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">1800062</td><td align="center">13</td><td align="center">BR1_010574</td><td align="center">41176528</td><td align="center">38521289</td><td align="center">g</td><td align="center">a</td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center"><underline>0.021</underline></td><td align="center">0.883</td><td></td><td></td></tr><tr><td align="left">8176101</td><td align="center">14</td><td align="center">BR1_010796</td><td align="center">41176306</td><td align="center">38521067</td><td align="center">a</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.021</underline></td><td align="center">0.882</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176103</td><td align="center">15</td><td align="center">C_2615171</td><td align="center">41175815</td><td align="center">38520576</td><td align="center">g</td><td align="center">a</td><td align="center">0.463</td><td align="center">0.291</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.234</td><td align="center">0.640</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176104</td><td align="center">16</td><td align="center">BR1_011340</td><td align="center">41175762</td><td align="center">38520523</td><td align="center">g</td><td align="center">a</td><td align="center">0.024</td><td align="center">0.824</td><td align="center">0.033</td><td align="center">0.789</td><td></td><td></td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176109</td><td align="center">17</td><td align="center">C_2615172</td><td align="center">41174541</td><td align="center">38519302</td><td align="center">a</td><td align="center">g</td><td align="center">0.441</td><td align="center">0.497</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.239</td><td align="center">0.609</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.469</td><td align="center">0.751</td></tr><tr><td align="left">8065872</td><td align="center">18</td><td align="center">BR1_016775</td><td align="center">41170328</td><td align="center">38515089</td><td align="center">t</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center">0.135</td><td align="center">0.278</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176120</td><td align="center">19</td><td align="center">BR1_017105</td><td align="center">41169998</td><td align="center">38514759</td><td align="center">g</td><td align="center">a</td><td align="center">0.424</td><td align="center">0.913</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.240</td><td align="center">0.550</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">799914</td><td align="center">20</td><td align="center">BR1_018573</td><td align="center">41168546</td><td align="center">38513307</td><td align="center">g</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.135</underline></td><td align="center">0.278</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">799913</td><td align="center">21</td><td align="center">BR1_019408</td><td align="center">41167711</td><td align="center">38512472</td><td align="center">a</td><td align="center">g</td><td align="center">0.032</td><td align="center">0.772</td><td align="center">0.042</td><td align="center">0.736</td><td align="center">0.365</td><td align="center">0.813</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176128</td><td align="center">22</td><td align="center">BR1_019904</td><td align="center">41167215</td><td align="center">38511976</td><td align="center">t</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176133</td><td align="center">23</td><td align="center">BR1_020896</td><td align="center">41166223</td><td align="center">38510984</td><td align="center">t</td><td align="center">g</td><td align="center">0.422</td><td align="center">0.738</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.167</td><td align="center">0.488</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">799912</td><td align="center">24</td><td align="center">C_2615180</td><td align="center">41165899</td><td align="center">38510660</td><td align="center">c</td><td align="center">t</td><td align="center">0.472</td><td align="center">0.701</td><td align="center">0.364</td><td align="center">0.926</td><td align="center">0.125</td><td align="center">0.322</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.489</td><td align="center">0.882</td></tr><tr><td align="left">799923</td><td align="center">25</td><td align="center">BR1_026422</td><td align="center">41160696</td><td align="center">38505457</td><td align="center">c</td><td align="center">t</td><td align="center">0.232</td><td align="center">0.031</td><td align="center">0.308</td><td align="center">0.858</td><td align="center">0.042</td><td align="center">0.763</td><td></td><td></td><td align="center">0.104</td><td align="center">0.459</td></tr><tr><td align="left">8176145</td><td align="center">26</td><td align="center">BR1_029258</td><td align="center">41157859</td><td align="center">38502620</td><td align="center">t</td><td align="center">c</td><td align="center">0.400</td><td align="center">0.038</td><td align="center">0.319</td><td align="center">0.586</td><td align="center">0.240</td><td align="center">0.550</td><td align="center">0.404</td><td align="center">0.309</td><td align="center">0.448</td><td align="center">0.829</td></tr><tr><td align="left">8176146</td><td align="center">27</td><td align="center">BR1_029448</td><td align="center">41157669</td><td align="center">38502430</td><td align="center">c</td><td align="center">t</td><td align="center">0.031</td><td align="center">0.774</td><td align="center">0.008</td><td align="center">0.948</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">7503154</td><td align="center">28</td><td align="center">BR1_030748</td><td align="center">41156369</td><td align="center">38501130</td><td align="center">t</td><td align="center">g</td><td align="center">0.415</td><td align="center">0.618</td><td align="center">0.339</td><td align="center">0.478</td><td align="center">0.223</td><td align="center">0.771</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.468</td><td align="center">0.862</td></tr><tr><td align="left">1799950</td><td align="center">29</td><td align="center">BR1_031875</td><td align="center">41155246</td><td align="center">38500007</td><td align="center">a</td><td align="center">g</td><td align="center">0.077</td><td align="center">0.442</td><td align="center">0.042</td><td align="center">0.736</td><td align="center">0.010</td><td align="center">0.942</td><td></td><td></td><td align="center">0.031</td><td align="center">0.823</td></tr><tr><td align="left">4986850</td><td align="center">30</td><td align="center">BR1_032885</td><td align="center">41154236</td><td align="center">38498997</td><td align="center">g</td><td align="center">a</td><td align="center">0.133</td><td align="center">0.096</td><td align="center">0.113</td><td align="center">0.071</td><td align="center">0.033</td><td align="center">0.819</td><td></td><td></td><td align="center">0.013</td><td align="center">0.935</td></tr><tr><td align="left">16940</td><td align="center">31</td><td align="center">BR1_033119</td><td align="center">41154002</td><td align="center">38498763</td><td align="center">t</td><td align="center">c</td><td align="center">0.422</td><td align="center">0.429</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.177</td><td align="center">0.624</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.448</td><td align="center">0.829</td></tr><tr><td align="left">799917</td><td align="center">32</td><td align="center">BR1_033420</td><td align="center">41153701</td><td align="center">38498462</td><td align="center">c</td><td align="center">t</td><td align="center">0.429</td><td align="center">0.766</td><td align="center">0.358</td><td align="center">0.868</td><td align="center">0.125</td><td align="center">0.322</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.479</td><td align="center">0.571</td></tr><tr><td align="left">4986852</td><td align="center">33</td><td align="center">BR1_003927</td><td align="center">41153194</td><td align="center">38497955</td><td align="center">g</td><td align="center">a</td><td align="center">0.012</td><td align="center">0.912</td><td align="center">0.042</td><td align="center">0.736</td><td align="center">0.010</td><td align="center">0.942</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">2227945</td><td align="center">34</td><td align="center">BR1_034226</td><td align="center">41152895</td><td align="center">38497656</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.052</underline></td><td align="center">0.703</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">16942</td><td align="center">35</td><td align="center">BR1_034356</td><td align="center">41152765</td><td align="center">38497526</td><td align="center">a</td><td align="center">g</td><td align="center">0.433</td><td align="center">0.868</td><td align="center">0.348</td><td align="center">0.615</td><td align="center">0.245</td><td align="center">0.521</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.447</td><td align="center">0.716</td></tr><tr><td align="left">799916</td><td align="center">36</td><td align="center">C_7530109</td><td align="center">41151955</td><td align="center">38496716</td><td align="center">t</td><td align="center">g</td><td align="center">0.438</td><td align="center">0.482</td><td align="center">0.358</td><td align="center">0.868</td><td align="center">0.271</td><td align="center">0.703</td><td align="center">0.394</td><td align="center">0.433</td><td align="center">0.479</td><td align="center">0.894</td></tr><tr><td align="left">2070833</td><td align="center">37</td><td align="center">BR1_035507</td><td align="center">41151614</td><td align="center">38496375</td><td align="center">c</td><td align="center">a</td><td align="center">0.031</td><td align="center">0.001</td><td></td><td></td><td></td><td></td><td align="center">0.271</td><td align="center">0.726</td><td align="center">0.135</td><td align="center">0.167</td></tr><tr><td align="left">2070834</td><td align="center">38</td><td align="center">BR1_036077</td><td align="center">41151050</td><td align="center">38495811</td><td align="center">a</td><td align="center">c</td><td align="center">0.435</td><td align="center">0.626</td><td align="center">0.342</td><td align="center">0.568</td><td align="center">0.250</td><td align="center">1.000</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.438</td><td align="center">0.634</td></tr><tr><td align="left">8176158</td><td align="center">39</td><td align="center">BR1_036793</td><td align="center">41150334</td><td align="center">38495095</td><td align="center">a</td><td align="center">g</td><td align="center">0.418</td><td align="center">0.393</td><td align="center">0.353</td><td align="center">0.665</td><td align="center">0.174</td><td align="center">0.532</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176160</td><td align="center">40</td><td align="center">BR1_036859</td><td align="center">41150268</td><td align="center">38495029</td><td align="center">a</td><td align="center">g</td><td align="center">0.435</td><td align="center">0.626</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.240</td><td align="center">0.550</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176166</td><td align="center">41</td><td align="center">BR1_038085</td><td align="center">41149042</td><td align="center">38493803</td><td align="center">a</td><td align="center">g</td><td align="center">0.196</td><td align="center">0.391</td><td align="center">0.150</td><td align="center">0.172</td><td align="center">0.104</td><td align="center">0.022</td><td align="center">0.120</td><td align="center">0.632</td><td align="center">0.344</td><td align="center">0.395</td></tr><tr><td align="left">8176174</td><td align="center">42</td><td align="center">BR1_040350</td><td align="center">41146777</td><td align="center">38491538</td><td align="center">a</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">3950989</td><td align="center">43</td><td align="center">C_3178696</td><td align="center">41146718</td><td align="center">38491479</td><td align="center">g</td><td align="center">a</td><td align="center">0.441</td><td align="center">0.566</td><td align="center">0.348</td><td align="center">0.615</td><td align="center">0.234</td><td align="center">0.640</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.457</td><td align="center">0.923</td></tr><tr><td align="left">8176175</td><td align="center">44</td><td align="center">BR1_040669</td><td align="center">41146458</td><td align="center">38491220</td><td align="center">t</td><td align="center">-</td><td align="center">0.006</td><td align="center">0.956</td><td></td><td></td><td></td><td></td><td align="center">0.073</td><td align="center">0.586</td><td></td><td></td></tr><tr><td align="left">8176177</td><td align="center">45</td><td align="center">BR1_041288</td><td align="center">41145840</td><td align="center">38490601</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.021</underline></td><td align="center">0.883</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176178</td><td align="center">46</td><td align="center">BR1_041721</td><td align="center">41145407</td><td align="center">38490168</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.042</underline></td><td align="center">0.763</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">1060915</td><td align="center">47</td><td align="center">C_3178676</td><td align="center">41143235</td><td align="center">38487996</td><td align="center">a</td><td align="center">g</td><td align="center">0.380</td><td align="center">0.105</td><td align="center">0.352</td><td align="center">0.851</td><td align="center">0.177</td><td align="center">0.624</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.468</td><td align="center">0.862</td></tr><tr><td align="left">3737559</td><td align="center">48</td><td align="center">C_3178677</td><td align="center">41143069</td><td align="center">38487830</td><td align="center">c</td><td align="center">t</td><td align="center">0.124</td><td align="center">0.481</td><td align="center">0.067</td><td align="center">0.580</td><td></td><td></td><td align="center">0.083</td><td align="center">0.208</td><td align="center">0.043</td><td align="center">0.761</td></tr><tr><td align="left">8176187</td><td align="center">49</td><td align="center">BR1_045154</td><td align="center">41141974</td><td align="center">38486735</td><td align="center">t</td><td align="center">c</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center"><underline>0.010</underline></td><td align="center">0.942</td></tr><tr><td align="left">8176188</td><td align="center">50</td><td align="center">BR1_045505</td><td align="center">41141623</td><td align="center">38486384</td><td align="center">t</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">6416927</td><td align="center">51</td><td align="center">BR1_0046019</td><td align="center">41141109</td><td align="center">38485870</td><td align="center">g</td><td align="center">c</td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center"><underline>0.083</underline></td><td align="center">0.208</td><td></td><td></td></tr><tr><td align="left">8176198</td><td align="center">52</td><td align="center">BR1_047826</td><td align="center">41139302</td><td align="center">38484063</td><td align="center">t</td><td align="center">a</td><td align="center">0.422</td><td align="center">0.429</td><td align="center">0.362</td><td align="center">0.427</td><td align="center">0.348</td><td align="center">0.114</td><td align="center">0.426</td><td align="center">0.761</td><td align="center">0.479</td><td align="center">0.571</td></tr><tr><td align="left">8176199</td><td align="center">53</td><td align="center">BR1_0477839</td><td align="center">41139289</td><td align="center">38484050</td><td align="center">a</td><td align="center">c</td><td align="center">0.341</td><td align="center">0.594</td><td align="center">0.258</td><td align="center">0.502</td><td align="center">0.135</td><td align="center">0.167</td><td align="center">0.177</td><td align="center">0.624</td><td align="center">0.396</td><td align="center">0.135</td></tr><tr><td align="left">4239147</td><td align="center">54</td><td align="center">BR1_048551</td><td align="center">41138577</td><td align="center">38483338</td><td align="center">t</td><td align="center">c</td><td align="center">0.440</td><td align="center">0.640</td><td align="center">0.324</td><td align="center">0.677</td><td align="center">0.271</td><td align="center">0.703</td><td align="center">0.394</td><td align="center">0.433</td><td align="center">0.452</td><td align="center">0.711</td></tr><tr><td align="left">8176206</td><td align="center">55</td><td align="center">BR1_050244</td><td align="center">41136885</td><td align="center">38481646</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center">0.052</td><td align="center">0.703</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">2236762</td><td align="center">56</td><td align="center">C_11621042</td><td align="center">41135440</td><td align="center">38480201</td><td align="center">a</td><td align="center">t</td><td align="center">0.435</td><td align="center">0.626</td><td align="center">0.358</td><td align="center">0.868</td><td align="center">0.271</td><td align="center">0.703</td><td align="center">0.406</td><td align="center">0.581</td><td align="center">0.479</td><td align="center">0.894</td></tr><tr><td align="left">1799966</td><td align="center">57</td><td align="center">C_2615208</td><td align="center">41131859</td><td align="center">38476620</td><td align="center">t</td><td align="center">c</td><td align="center">0.456</td><td align="center">0.456</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.233</td><td align="center">0.781</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.469</td><td align="center">0.751</td></tr><tr><td align="left">3092987</td><td align="center">58</td><td align="center">BR1_055669</td><td align="center">41131488</td><td align="center">38476249</td><td align="center">a</td><td align="center">g</td><td align="center">0.416</td><td align="center">0.545</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.170</td><td align="center">0.510</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176225</td><td align="center">59</td><td align="center">BR1_056796</td><td align="center">41130361</td><td align="center">38475122</td><td align="center">g</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.031</underline></td><td align="center">0.823</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176232</td><td align="center">60</td><td align="center">BR1_058369</td><td align="center">41128788</td><td align="center">38473549</td><td align="center">c</td><td align="center">t</td><td align="center"><underline>0.013</underline></td><td align="center">0.936</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176234</td><td align="center">61</td><td align="center">BR1_058614</td><td align="center">41128545</td><td align="center">38473306</td><td align="center">a</td><td align="center">g</td><td align="center">0.437</td><td align="center">0.345</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.239</td><td align="center">0.609</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176235</td><td align="center">62</td><td align="center">BR1_058834</td><td align="center">41128325</td><td align="center">38473086</td><td align="center">g</td><td align="center">a</td><td align="center">0.339</td><td align="center">0.872</td><td align="center">0.258</td><td align="center">0.502</td><td align="center">0.167</td><td align="center">0.488</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.436</td><td align="center">0.972</td></tr><tr><td align="left">8176236</td><td align="center">63</td><td align="center">BR1_059589</td><td align="center">41127570</td><td align="center">38472331</td><td align="center">t</td><td align="center">c</td><td></td><td></td><td align="center">0.008</td><td align="center">0.948</td><td align="center">0.359</td><td align="center">0.556</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176240</td><td align="center">64</td><td align="center">BR1_060022</td><td align="center">41127137</td><td align="center">38471898</td><td align="center">t</td><td align="center">c</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176242</td><td align="center">65</td><td align="center">BR1_060520</td><td align="center">41126639</td><td align="center">38471400</td><td align="center">g</td><td align="center">a</td><td align="center">0.433</td><td align="center">0.538</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.170</td><td align="center">0.510</td><td align="center">0.406</td><td align="center">0.581</td><td align="center">0.458</td><td align="center">0.961</td></tr><tr><td align="left">8176245</td><td align="center">66</td><td align="center">BR1_061014</td><td align="center">41126145</td><td align="center">38470906</td><td align="center">t</td><td align="center">c</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">3092994</td><td align="center">67</td><td align="center">C_2615220</td><td align="center">41124590</td><td align="center">38469351</td><td align="center">c</td><td align="center">t</td><td align="center">0.434</td><td align="center">0.471</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.228</td><td align="center">0.242</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.266</td><td align="center">0.808</td></tr><tr><td align="left">8176259</td><td align="center">68</td><td align="center">BR1_062588</td><td align="center">41124571</td><td align="center">38469332</td><td align="center">t</td><td align="center">-</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.052</underline></td><td align="center">0.703</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176265</td><td align="center">69</td><td align="center">BR1_0064398</td><td align="center">41122761</td><td align="center">38467522</td><td align="center">g</td><td align="center">a</td><td align="center">0.417</td><td align="center">0.477</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.167</td><td align="center">0.729</td><td align="center">0.394</td><td align="center">0.433</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">2187603</td><td align="center">70</td><td align="center">BR1_064501</td><td align="center">41122658</td><td align="center">38467419</td><td align="center">g</td><td align="center">a</td><td align="center">0.422</td><td align="center">0.429</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.167</td><td align="center">0.729</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">8176273</td><td align="center">71</td><td align="center">BR1_066741</td><td align="center">41120418</td><td align="center">38465179</td><td align="center">t</td><td align="center">c</td><td align="center">0.424</td><td align="center">0.580</td><td align="center">0.342</td><td align="center">0.568</td><td align="center">0.167</td><td align="center">0.729</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">8176278</td><td align="center">72</td><td align="center">BR1_067978</td><td align="center">41119181</td><td align="center">38463942</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td align="center">0.008</td><td align="center">0.948</td><td align="center">0.500</td><td align="center">0.564</td><td></td><td></td><td align="center">0.021</td><td align="center">0.883</td></tr><tr><td align="left">8066171</td><td align="center">73</td><td align="center">BR1_068063</td><td align="center">41119096</td><td align="center">38463857</td><td align="center">g</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center">0.146</td><td align="center">0.237</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">NA</td><td align="center">74</td><td align="center">M_5382insC</td><td align="center">41117845</td><td align="center">38462606</td><td align="center">-</td><td align="center">c</td><td align="center"><underline>0.006</underline></td><td align="center">0.957</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176289</td><td align="center">75</td><td align="center">C_2615230</td><td align="center">41114821</td><td align="center">38459582</td><td align="center">t</td><td align="center">c</td><td align="center">0.441</td><td align="center">0.566</td><td align="center">0.342</td><td align="center">0.568</td><td align="center">0.223</td><td align="center">0.258</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.266</td><td align="center">0.808</td></tr><tr><td align="left">8176293</td><td align="center">76</td><td align="center">BR1_073023</td><td align="center">41114136</td><td align="center">38458897</td><td align="center">a</td><td align="center">-</td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center"><underline>0.031</underline></td><td align="center">0.823</td><td></td><td></td></tr><tr><td align="left">4793192</td><td align="center">77</td><td align="center">BR1_074008</td><td align="center">41113155</td><td align="center">38457916</td><td align="center">a</td><td align="center">g</td><td align="center">0.435</td><td align="center">0.626</td><td align="center">0.336</td><td align="center">0.794</td><td align="center">0.229</td><td align="center">0.214</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">8176296</td><td align="center">78</td><td align="center">BR1_074807</td><td align="center">41112356</td><td align="center">38457117</td><td align="center">a</td><td align="center">g</td><td align="center">0.435</td><td align="center">0.703</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.229</td><td align="center">0.214</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">3092988</td><td align="center">79</td><td align="center">C_2615238</td><td align="center">41110467</td><td align="center">38455228</td><td align="center">c</td><td align="center">t</td><td align="center">0.424</td><td align="center">0.580</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.170</td><td align="center">0.709</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">8176303</td><td align="center">80</td><td align="center">BR1_076933</td><td align="center">41110230</td><td align="center">38454991</td><td align="center">a</td><td align="center">g</td><td></td><td></td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td><td align="center">0.042</td><td align="center">0.763</td><td></td><td></td></tr><tr><td align="left">8176305</td><td align="center">81</td><td align="center">BR1_077034</td><td align="center">41110129</td><td align="center">38454890</td><td align="center">a</td><td align="center">g</td><td align="center">0.094</td><td align="center">0.753</td><td align="center">0.092</td><td align="center">0.442</td><td align="center">0.021</td><td align="center">0.883</td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176307</td><td align="center">82</td><td align="center">BR1_077328</td><td align="center">41109835</td><td align="center">38454596</td><td align="center">t</td><td align="center">c</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.063</underline></td><td align="center">0.644</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8068463</td><td align="center">83</td><td align="center">BR1_079220</td><td align="center">41107943</td><td align="center">38452704</td><td align="center">c</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.125</underline></td><td align="center">0.322</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176313</td><td align="center">84</td><td align="center">BR1_079396</td><td align="center">41107767</td><td align="center">38452528</td><td align="center">g</td><td align="center">a</td><td align="center">0.006</td><td align="center">0.957</td><td align="center">0.017</td><td align="center">0.896</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176316</td><td align="center">85</td><td align="center">BR1_080570</td><td align="center">41106594</td><td align="center">38451355</td><td align="center">c</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.021</underline></td><td align="center">0.883</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176318</td><td align="center">86</td><td align="center">BR1_081125</td><td align="center">41106039</td><td align="center">38450800</td><td align="center">g</td><td align="center">t</td><td align="center">0.435</td><td align="center">0.963</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.167</td><td align="center">0.729</td><td align="center">0.385</td><td align="center">0.491</td><td align="center">0.250</td><td align="center">1.000</td></tr><tr><td align="left">12516</td><td align="center">87</td><td align="center">BR1_081990</td><td align="center">41105173</td><td align="center">38449934</td><td align="center">c</td><td align="center">t</td><td align="center">0.435</td><td align="center">0.626</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.229</td><td align="center">0.214</td><td align="center">0.406</td><td align="center">0.581</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">8176320</td><td align="center">88</td><td align="center">BR1_082035</td><td align="center">41105128</td><td align="center">38449889</td><td align="center">g</td><td align="center">a</td><td align="center">0.006</td><td align="center">0.957</td><td align="center">0.033</td><td align="center">0.789</td><td></td><td></td><td></td><td></td><td align="center">0.010</td><td align="center">0.942</td></tr><tr><td align="left">8176321</td><td align="center">89</td><td align="center">BR1_082199</td><td align="center">41104964</td><td align="center">38449725</td><td align="center">g</td><td align="center">a</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.010</underline></td><td align="center">0.942</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">8176323</td><td align="center">90</td><td align="center">BR1_082687</td><td align="center">41104476</td><td align="center">38449237</td><td align="center">c</td><td align="center">g</td><td align="center">0.429</td><td align="center">0.766</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.229</td><td align="center">0.214</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">7223952</td><td align="center">91</td><td align="center">C_11621012</td><td align="center">41103649</td><td align="center">38448411</td><td align="center">t</td><td align="center">c</td><td align="center">0.441</td><td align="center">0.566</td><td align="center">0.356</td><td align="center">0.765</td><td align="center">0.281</td><td align="center">0.569</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.287</td><td align="center">0.931</td></tr><tr><td align="left">9911630</td><td align="center">92</td><td align="center">C_3178665</td><td align="center">41097108</td><td align="center">38441868</td><td align="center">a</td><td align="center">g</td><td align="center">0.422</td><td align="center">0.429</td><td align="center">0.364</td><td align="center">0.926</td><td align="center">0.266</td><td align="center">0.808</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.283</td><td align="center">0.813</td></tr><tr><td align="left">11460963</td><td align="center">93</td><td align="center">C_2615245</td><td align="center">41090062</td><td align="center">38435121</td><td align="center">-</td><td align="center">g</td><td align="center">0.441</td><td align="center">0.497</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.228</td><td align="center">0.242</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.266</td><td align="center">0.808</td></tr><tr><td align="left">2298861</td><td align="center">94</td><td align="center">C_3178699</td><td align="center">41085596</td><td align="center">38430357</td><td align="center">g</td><td align="center">a</td><td align="center">0.441</td><td align="center">0.309</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.223</td><td align="center">0.258</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.266</td><td align="center">0.808</td></tr><tr><td align="left">2298862</td><td align="center">95</td><td align="center">C_3178698</td><td align="center">41085453</td><td align="center">38430214</td><td align="center">t</td><td align="center">c</td><td align="center">0.447</td><td align="center">0.383</td><td align="center">0.350</td><td align="center">0.712</td><td align="center">0.208</td><td align="center">0.343</td><td align="center">0.396</td><td align="center">0.359</td><td align="center">0.260</td><td align="center">0.848</td></tr><tr><td align="left">443759</td><td align="center">96</td><td align="center">C_2287905</td><td align="center">41074499</td><td align="center">38419260</td><td align="center">c</td><td align="center">t</td><td align="center">0.229</td><td align="center">0.129</td><td align="center">0.241</td><td align="center">0.656</td><td align="center">0.354</td><td align="center">0.520</td><td align="center">0.083</td><td align="center">0.208</td><td align="center">0.146</td><td align="center">0.981</td></tr><tr><td align="left">11871636</td><td align="center">97</td><td align="center">C_11617231</td><td align="center">41063582</td><td align="center">38408343</td><td align="center">a</td><td align="center">c</td><td align="center">0.235</td><td align="center">0.304</td><td align="center">0.259</td><td align="center">0.386</td><td align="center">0.302</td><td align="center">0.345</td><td align="center">0.167</td><td align="center">0.083</td><td align="center">0.135</td><td align="center">0.278</td></tr><tr><td align="left">2271539</td><td align="center">98</td><td align="center">C_1588447</td><td align="center">41059714</td><td align="center">38404475</td><td align="center">a</td><td align="center">g</td><td align="center">0.388</td><td align="center">0.932</td><td align="center">0.388</td><td align="center">0.339</td><td align="center">0.213</td><td align="center">0.447</td><td align="center">0.448</td><td align="center">0.341</td><td align="center">0.277</td><td align="center">0.768</td></tr><tr><td align="left">690971</td><td align="center">99</td><td align="center">C_765227</td><td align="center">41025330</td><td align="center">38370091</td><td align="center">g</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center"><underline>0.281</underline></td><td align="center">0.885</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">528854</td><td align="center">100</td><td align="center">C_1588417</td><td align="center">41006873</td><td align="center">38351634</td><td align="center">a</td><td align="center">g</td><td align="center">0.106</td><td align="center">0.230</td><td align="center">0.098</td><td align="center">0.488</td><td align="center">0.479</td><td align="center">0.990</td><td></td><td></td><td align="center">0.063</td><td align="center">0.644</td></tr><tr><td align="left">323495</td><td align="center">101</td><td align="center">C_1588405</td><td align="center">40983252</td><td align="center">38328013</td><td align="center">g</td><td align="center">a</td><td align="center">0.316</td><td align="center">0.182</td><td align="center">0.342</td><td align="center">0.568</td><td align="center">0.208</td><td align="center">0.001</td><td align="center">0.396</td><td align="center">0.135</td><td align="center">0.443</td><td align="center">0.407</td></tr><tr><td align="left">2593595</td><td align="center">102</td><td align="center">C_3256885</td><td align="center">40965010</td><td align="center">38309771</td><td align="center">a</td><td align="center">g</td><td align="center">0.124</td><td align="center">0.007</td><td align="center">0.054</td><td align="center">0.672</td><td align="center">0.156</td><td align="center">0.002</td><td align="center">0.135</td><td align="center">0.883</td><td align="center">0.177</td><td align="center">&#x0003c;.0001</td></tr><tr><td align="left">324075</td><td align="center">103</td><td align="center">C_3256881</td><td align="center">40935288</td><td align="center">38280049</td><td align="center">a</td><td align="center">g</td><td align="center">0.171</td><td align="center">0.717</td><td align="center">0.195</td><td align="center">0.063</td><td align="center">0.115</td><td align="center">0.370</td><td align="center">0.156</td><td align="center">0.365</td><td align="center">0.330</td><td align="center">0.558</td></tr><tr><td align="left">2290041</td><td align="center">104</td><td align="center">C_15883310</td><td align="center">40856085</td><td align="center">38200846</td><td align="center">c</td><td align="center">t</td><td align="center">0.012</td><td align="center">0.913</td><td></td><td></td><td align="center">0.302</td><td align="center">0.103</td><td align="center">0.031</td><td align="center">0.823</td><td></td><td></td></tr><tr><td align="left">1078523</td><td align="center">105</td><td align="center">C_2160077</td><td align="center">40821525</td><td align="center">38166286</td><td align="center">a</td><td align="center">g</td><td align="center">0.480</td><td align="center">0.158</td><td align="center">0.370</td><td align="center">0.650</td><td align="center">0.135</td><td align="center">0.883</td><td align="center">0.478</td><td align="center">0.369</td><td align="center">0.474</td><td align="center">0.075</td></tr><tr><td align="left">752313</td><td align="center">106</td><td align="center">C_1075621</td><td align="center">40810589</td><td align="center">38155350</td><td align="center">t</td><td align="center">c</td><td align="center">0.363</td><td align="center">0.314</td><td align="center">0.422</td><td align="center">0.851</td><td align="center">0.292</td><td align="center">0.954</td><td align="center">0.406</td><td align="center">0.250</td><td align="center">0.351</td><td align="center">0.251</td></tr><tr><td align="left">7359598</td><td align="center">107</td><td align="center">C_3256867</td><td align="center">40806234</td><td align="center">38150996</td><td align="center">c</td><td align="center">t</td><td align="center">0.386</td><td align="center">0.073</td><td align="center">0.440</td><td align="center">0.674</td><td align="center">0.135</td><td align="center">0.883</td><td align="center">0.438</td><td align="center">0.486</td><td align="center">0.383</td><td align="center">0.243</td></tr><tr><td align="left">2271027</td><td align="center">108</td><td align="center">C_15959277</td><td align="center">40779567</td><td align="center">38124328</td><td align="center">c</td><td align="center">t</td><td></td><td></td><td></td><td></td><td align="center">0.065</td><td align="center">0.636</td><td align="center">0.031</td><td align="center">0.823</td><td></td><td></td></tr><tr><td align="left">7214055</td><td align="center">109</td><td align="center">C_1441435</td><td align="center">40761936</td><td align="center">38106697</td><td align="center">c</td><td align="center">g</td><td align="center">0.149</td><td align="center">0.109</td><td align="center">0.008</td><td align="center">0.948</td><td align="center">0.385</td><td align="center">0.003</td><td align="center">0.031</td><td align="center">0.823</td><td align="center">0.021</td><td align="center">0.882</td></tr><tr><td align="left">9766</td><td align="center">110</td><td align="center">C_1441436</td><td align="center">40761606</td><td align="center">38106367</td><td align="center">g</td><td align="center">a</td><td align="center">0.353</td><td align="center">0.219</td><td align="center">0.433</td><td align="center">0.700</td><td align="center">0.292</td><td align="center">0.954</td><td align="center">0.406</td><td align="center">0.250</td><td align="center">0.344</td><td align="center">0.823</td></tr><tr><td align="left">1553469</td><td align="center">111</td><td align="center">C_7529639</td><td align="center">40751527</td><td align="center">38096288</td><td align="center">a</td><td align="center">c</td><td align="center">0.065</td><td align="center">0.248</td><td align="center">0.058</td><td align="center">0.061</td><td align="center">0.031</td><td align="center">&#x0003c;.0001</td><td></td><td></td><td align="center">0.202</td><td align="center">0.943</td></tr><tr><td align="left">2271029</td><td align="center">112</td><td align="center">C_1125369</td><td align="center">40744687</td><td align="center">38089448</td><td align="center">c</td><td align="center">a</td><td align="center">0.405</td><td align="center">0.009</td><td align="center">0.350</td><td align="center">0.444</td><td align="center">0.375</td><td align="center">0.441</td><td align="center">0.385</td><td align="center">0.937</td><td align="center">0.402</td><td align="center">0.117</td></tr><tr><td align="left">3760384</td><td align="center">113</td><td align="center">C_1441438</td><td align="center">40744216</td><td align="center">38088977</td><td align="center">a</td><td align="center">c</td><td align="center">0.359</td><td align="center">0.020</td><td align="center">0.392</td><td align="center">0.666</td><td align="center">0.447</td><td align="center">0.716</td><td align="center">0.385</td><td align="center">0.937</td><td align="center">0.458</td><td align="center">0.023</td></tr><tr><td align="left">2292749</td><td align="center">114</td><td align="center">C_1441444</td><td align="center">40727349</td><td align="center">38072110</td><td align="center">c</td><td align="center">t</td><td align="center">0.217</td><td align="center">0.219</td><td align="center">0.383</td><td align="center">0.518</td><td align="center">0.192</td><td align="center">0.794</td><td align="center">0.375</td><td align="center">0.878</td><td align="center">0.128</td><td align="center">0.316</td></tr><tr><td colspan="17"><hr></hr></td></tr><tr><td align="left" colspan="7">Number of polymorphic loci</td><td align="center">83</td><td></td><td align="center">80</td><td></td><td align="center">99</td><td></td><td align="center">71</td><td></td><td align="center">82</td><td></td></tr><tr><td align="left" colspan="7">Number of SNPs with maf&#x0003c;0.05</td><td align="center">11</td><td></td><td align="center">13</td><td></td><td align="center">14</td><td></td><td align="center">6</td><td></td><td align="center">17</td><td></td></tr><tr><td align="left" colspan="7">Mean maf</td><td align="center">0.305</td><td></td><td align="center">0.269</td><td></td><td align="center">0.181</td><td></td><td align="center">0.327</td><td></td><td align="center">0.287</td><td></td></tr></tbody></table><table-wrap-foot><p><sup>a </sup>April 2003 (Build 33) Position</p><p><sup>b </sup>March 2006 (Build 36.1) Position</p><p><sup>c </sup>Com Allele = Common allele</p><p><sup>d </sup>Min Allele = Minor allele</p><p><sup>e </sup>maf = Minor allele frequency</p><p><sup>f </sup>Population private SNPs are shown underlined</p><p><sup>g</sup>NA= Not Applicable &#x02013; not in dbSNP</p></table-wrap-foot></table-wrap></sec><sec><title>LD structure</title><p>In order to analyze the LD structure at the <italic>BRCA1 </italic>locus, we chose two methods that rely on different premises. The first is <italic>haplotype block analysis </italic>which identifies sequential and non-overlapping sets of variants in high LD, separated by low levels of LD that are consistent with historical recombination. In this method, all htSNPs need to be genotyped in order to capture most of the genetic variation [<xref ref-type="bibr" rid="B27">27</xref>]. The second is a <italic>binning method </italic>in which SNPs in one LD bin can be interleaved with SNPs in other overlapping bins. Under this approach, one TagSNP per bin needs to be tested in order to capture SNP diversity [<xref ref-type="bibr" rid="B28">28</xref>].</p><p>Our analyses of D' and <italic>r</italic><sup>2 </sup>showed <italic>BRCA1 </italic>residing in a large region (~288 kb) of high LD (Fig. <xref ref-type="fig" rid="F1">1</xref>), in agreement with other reports [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. The entire region studied showed long-range LD, falling primarily into three blocks among non-African populations. The block containing <italic>BRCA1 </italic>includes 95 SNPs and overlaps the largest LDSelect bin of SNPs correlated at <italic>r</italic><sup>2 </sup>&#x0003e; 0.8 (Fig. <xref ref-type="fig" rid="F2">2</xref> and Fig. <xref ref-type="fig" rid="F3">3</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Comparison of haplotype blocks at 114 loci across five populations</bold>. Blocks were defined as in [27]; markers with MAF &#x0003c;0.05 are shown with a white background and were ignored in the calculations and block boundary estimation. Haplotype tag SNPs (htSNPs) within a block are indicated by arrowheads; htSNPs in only one population are shown on a yellow background while the single htSNP shared between all populations is shown on a green background.</p></caption><graphic xlink:href="1471-2156-8-68-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Comparison of SNP bins derived from pair-wise measurements of linkage disequilibrium using LDSelect-Comp</bold>. SNPs with MAF &#x0003c; 5% do not have a vertical line or arrowhead in the column. A) Scale representation of the ~650 kb region studied, indicating the <italic>BRCA1 </italic>gene, founder mutations, and genome sequence gap of unknown true size. Anchor lines link to position of the SNP within the region. B-F) LDSelect creates bins of SNPs that have an <italic>r</italic><sup>2 </sup>value of 0.8 or greater with at least one other SNP in the bin. Each vertical line and arrowhead represents a SNP, with dashed lines and shaded background connecting SNPs within the same bin. Down arrowheads indicate Tag SNPs (those with <italic>r</italic><sup>2 </sup>&#x02265; 0.8 with all other SNPs in a bin). Note that this use of the term Tag-SNP is different from Haploview &#x02013; with LDSelect, only one Tag-SNP per bin would be required to capture the majority of the nucleotide diversity. Singleton bins (SNPs that did not have <italic>r</italic><sup>2 </sup>&#x02265; 0.8 with any other SNP) are indicated by solid dots on a single row. SNP number refers to numbering in column 1 of Table 1.</p></caption><graphic xlink:href="1471-2156-8-68-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Pair-wise measures of linkage disequilibrium and the two founder mutation-containing haplotypes</bold>. SNP number refers to numbering in column 1 of Table 1; only the 70 with MAF &#x02265; 0.05 in Ashkenazi Jews are shown in B-D. A) Scale representation of the ~650 kb region studied, indicating the <italic>BRCA1 </italic>gene, founder mutations, and genome sequence gap of unknown true size. B) LDSelect-Comp output showing a total of 22 bins for Ashkenazi Jews, with 17 "singleton" bins indicated by solid dots on a single row. C) Haploview output showing three block structures and related ht-SNPs (indicated with up arrowheads). D) Haplotypes estimated for 85 unrelated Ashkenazi Jews using SNPHAP as implemented in HapScope. The block boundaries were calculated in Haploview and overlaid on this figure. All haplotypes with an estimated frequency of at least 1% are displayed (h1 to h11), with individual frequencies and sums indicated to the right of the blocks. The common allele is designated "1" and the minor allele "2". The 185delAG and 5382insC containing haplotypes, determined from the family based genotypes, are indicated with gray (haplotype 2) and blue background (haplotype 1), respectively. Black arrows indicate the relative position of these two founder mutations.</p></caption><graphic xlink:href="1471-2156-8-68-3"/></fig><p>African-Americans presented the least LD of all populations, with the presence of more distinct blocks within the region (Fig. <xref ref-type="fig" rid="F1">1</xref>). Maps for all five populations shared a break-point that maps approximately 20 kb downstream of the <italic>BRCA1 </italic>gene, between SNP95 (rs2298862) and SNP96 (rs443759). Among non-African groups, only Mexican-Americans exhibited an additional break point within the 288 kb block structure that encompasses <italic>BRCA1</italic>. The 3'end of the entire region showed less extensive LD but a similar pattern across all the groups. Only one htSNP (SNP3 &#x02013; rs17599948) was found to be completely shared across populations, which is not unexpected since htSNPs often are population-specific [<xref ref-type="bibr" rid="B28">28</xref>] (Fig. <xref ref-type="fig" rid="F1">1</xref>).</p><p>When the bin-based approach was used, we found that bins were largely shared across different ethnic groups (Fig. <xref ref-type="fig" rid="F2">2</xref>). The differences across populations were related to the number of bins as well as the number and position of TagSNPs. As expected, African-Americans were the most diverse group, containing the highest number of bins (34), followed by Ashkenazi Jews (22), CEPH (19), Mexican-Americans and Chinese-American (14). This contrasts with 28 htSNPs in African-Americans, and 16, 13, 25 and 18 among Ashkenazi Jews, CEPH, Mexican- Americans and Chinese-Americans, respectively. Three TagSNPs were shared by all populations (SNP3 &#x02013; rs17599948, SNP41 &#x02013; rs8176166, and SNP67 &#x02013; rs3092994), showing average MAF of 0.193, 0.183 and 0.335, respectively (Fig. <xref ref-type="fig" rid="F2">2</xref>). Mexican-Americans showed two disjoint bins of highly-correlated SNPs, rather than one extended bin structure as evidenced in Ashkenazim, CEPH and Chinese-Americans. The disjoint occurred between positions 38,471,400 (SNP65 &#x02013; rs8176242) and 38,469,351 (SNP67 &#x02013; rs3092994), mapping between introns 17 and 18 of <italic>BRCA1 </italic>(Fig. <xref ref-type="fig" rid="F2">2F</xref>). Interestingly, our results resemble what others have observed [<xref ref-type="bibr" rid="B32">32</xref>] in Native- Americans, namely an historical recombination event between introns 15 and 18. All five populations showed a large bin spanning ~288 kb encompassing SNP1 (rs13119) through SNP95 (rs2298862) (Fig. <xref ref-type="fig" rid="F2">2A&#x02013;F</xref>), which represented the same extended region found in the block analysis. This large bin had 0.278 average MAF across populations and included <italic>BRCA1 </italic>coding polymorphisms L771L_(TTG&#x0003e;CTG), P871L_(CCG&#x0003e;CTG), 1183R_(AAA&#x0003e;AGA) and S1436S_(TCT&#x0003e;TCC) (Fig. <xref ref-type="fig" rid="F2">2</xref>).</p><p>The maps of linkage disequilibrium in LD units (LDU) corresponded well with the two previous approaches of assessing disequilibrium. The four major breakpoints that were observed in Fig. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>, when haplotype blocks and bin structures were inferred, coincided with the same major steps in the LDU analysis (Fig. <xref ref-type="fig" rid="F4">4</xref>). In addition, we were able to observe two small steps in Fig. <xref ref-type="fig" rid="F4">4</xref> for the Mexican-Americans, which were not observed in any other population. The first step occurred between SNP65 (rs8176242, intron 17) and SNP69 (rs8176265, intron 19). The corresponding site of possible recombination could be observed as a split at the main bin structure for Mexican-Americans in Fig. <xref ref-type="fig" rid="F2">2F</xref>. The second step was found between SNP90 (rs8176323) and SNP91 (rs7223952), downstream of the gene. A close correspondence was evidenced as a breakdown in LD around the same position in Fig. <xref ref-type="fig" rid="F1">1</xref>.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>LDU maps. Comparison of LDU maps across the ~650 kb region containing the <italic>BRCA1 </italic>gene for 5 populations</bold>. Top. Scale representation of the ~650 kb region studied, indicating the <italic>BRCA1 </italic>gene, founder mutations, and genome sequence gap of unknown true size. Bottom. LDU maps for five populations.</p></caption><graphic xlink:href="1471-2156-8-68-4"/></fig></sec><sec><title>185delAG and 5382insC haplotype reconstruction</title><p>We were particularly interested in fine mapping the <italic>BRCA1 </italic>locus to identify possible gene variants or haplotypes associated with the two founder mutations in Ashkenazi Jews. Therefore, 82 intragenic and 30 flanking SNPs were tested against the two founder mutations with the Pearson's correlation (<italic>r</italic>) coefficient (Table <xref ref-type="table" rid="T2">2</xref>). Although in strong LD with the majority of markers as measured by D' (Table <xref ref-type="table" rid="T2">2</xref>), the highest pair-wise <italic>r</italic><sup>2 </sup>for 185delAG was 0.04, owing to its relatively low frequency, with a common SNP (SNP96, rs443759) that mapped outside the large <italic>BRCA1</italic>-containing block, approximately 110 kb downstream of the gene. Regarding 5382insC, there was one highly-significant association (<italic>r</italic><sup>2 </sup>= 1.0) with SNP8 (rs8176072) (Table <xref ref-type="table" rid="T2">2</xref>). This is a rare SNP that was present only in 5382insC mutation carriers, and 5382insC was not correlated above 0.03 with any other SNP in the region.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Pair-wise correlation coefficients between the two founder <italic>BRCA1 </italic>mutations and all other SNPs among Ashkenazi Jews</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td></td><td align="center" colspan="3">Ashkenazim (n = 85)</td><td align="center" colspan="2">Correlation (<italic>r </italic><sup>2</sup>) with</td><td align="center">D' with</td><td align="center">D' with</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="3"><hr></hr></td><td colspan="4"><hr></hr></td></tr><tr><td align="left">SNP name</td><td align="left">rs number</td><td align="center">SNP number</td><td align="center">SNP description</td><td align="center">maf<sup>a</sup></td><td align="center">Het<sup>b</sup></td><td align="center">HW <italic>P</italic>-value</td><td align="center">185delAG</td><td align="center">5382insC</td><td align="center">185delAG</td><td align="center">5382insC</td></tr></thead><tbody><tr><td align="left">C_9270420</td><td align="left">13119</td><td align="center">1</td><td align="center">NBR1: UTR</td><td align="center">0.424</td><td align="center">0.52</td><td align="center">0.580</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_9270421</td><td align="left">748620</td><td align="center">2</td><td align="center">NBR1: UTR</td><td align="center">0.440</td><td align="center">0.52</td><td align="center">0.640</td><td align="center">0.016</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_9270454</td><td align="left">17599948</td><td align="center">3</td><td align="center">NBR1: intron</td><td align="center">0.211</td><td align="center">0.35</td><td align="center">0.649</td><td align="center">0.016</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_95201</td><td align="left">11653231</td><td align="center">4</td><td align="center">NBR1: intron</td><td align="center">0.435</td><td align="center">0.51</td><td align="center">0.703</td><td align="center">0.014</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178692</td><td align="left">9908805</td><td align="center">5</td><td align="center">LBRCA1: UTR</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_11631183</td><td align="left">2175957</td><td align="center">6</td><td align="center">NBR2: intron</td><td align="center">0.447</td><td align="center">0.52</td><td align="center">0.665</td><td align="center">0.013</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_000340</td><td align="left">3092986</td><td align="center">7</td><td align="center">NBR2: intron</td><td align="center">0.051</td><td align="center">0.10</td><td align="center">0.636</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_000392</td><td align="left">8176072</td><td align="center">8</td><td align="center">NBR2:intron</td><td align="center"><underline>0.006<sup>c</sup></underline></td><td align="center">0.01</td><td align="center">0.957</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_000571</td><td align="left">8176074</td><td align="center">9</td><td align="center">NBR2:UTR</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615164</td><td align="left">3765640</td><td align="center">10</td><td align="center">BRCA1:UTR</td><td align="center">0.440</td><td align="center">0.52</td><td align="center">0.640</td><td align="center">0.015</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">M_185delAG</td><td align="left">NA<sup>d</sup></td><td align="center">11</td><td align="center">BRCA1:exon 2</td><td align="center"><underline>0.006</underline></td><td align="center">0.01</td><td align="center">0.957</td><td align="center">NA</td><td align="center">0.000</td><td align="center">NA</td><td align="center">1.000</td></tr><tr><td align="left">BR1_007918</td><td align="left">8176090</td><td align="center">12</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_010574</td><td align="left">1800062</td><td align="center">13</td><td align="center">BRCA1: P_K38K_(AAG&#x0003e;AAA)</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_010796</td><td align="left">8176101</td><td align="center">14</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615171</td><td align="left">8176103</td><td align="center">15</td><td align="center">BRCA1: intron</td><td align="center">0.463</td><td align="center">0.56</td><td align="center">0.291</td><td align="center">0.014</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_011340</td><td align="left">8176104</td><td align="center">16</td><td align="center">BRCA1: intron</td><td align="center">0.024</td><td align="center">0.05</td><td align="center">0.824</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615172</td><td align="left">8176109</td><td align="center">17</td><td align="center">BRCA1: intron</td><td align="center">0.441</td><td align="center">0.53</td><td align="center">0.497</td><td align="center">0.011</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">BR1_016775</td><td align="left">8065872</td><td align="center">18</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_017105</td><td align="left">8176120</td><td align="center">19</td><td align="center">BRCA1: intron</td><td align="center">0.424</td><td align="center">0.49</td><td align="center">0.913</td><td align="center">0.015</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_018573</td><td align="left">799914</td><td align="center">20</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_019408</td><td align="left">799913</td><td align="center">21</td><td align="center">BRCA1: intron</td><td align="center">0.032</td><td align="center">0.06</td><td align="center">0.772</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_019904</td><td align="left">8176128</td><td align="center">22</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_020896</td><td align="left">8176133</td><td align="center">23</td><td align="center">BRCA1: intron</td><td align="center">0.422</td><td align="center">0.51</td><td align="center">0.738</td><td align="center">0.012</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615180</td><td align="left">799912</td><td align="center">24</td><td align="center">BRCA1: intron</td><td align="center">0.472</td><td align="center">0.52</td><td align="center">0.701</td><td align="center">0.011</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">BR1_026422</td><td align="left">799923</td><td align="center">25</td><td align="center">BRCA1: intron</td><td align="center">0.232</td><td align="center">0.44</td><td align="center">0.031</td><td align="center">0.003</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_029258</td><td align="left">8176145</td><td align="center">26</td><td align="center">BRCA1: intron</td><td align="center">0.400</td><td align="center">0.59</td><td align="center">0.038</td><td align="center">0.021</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">BR1_029448</td><td align="left">8176146</td><td align="center">27</td><td align="center">BRCA1: intron</td><td align="center">0.031</td><td align="center">0.06</td><td align="center">0.774</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_030748</td><td align="left">7503154</td><td align="center">28</td><td align="center">BRCA1: intron</td><td align="center">0.415</td><td align="center">0.51</td><td align="center">0.618</td><td align="center">0.012</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_031875</td><td align="left">1799950</td><td align="center">29</td><td align="center">BRCA1: P_Q356R_(CAG&#x0003e;CGG)</td><td align="center">0.077</td><td align="center">0.15</td><td align="center">0.442</td><td align="center">0.002</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_032885</td><td align="left">4986850</td><td align="center">30</td><td align="center">BRCA1: P_D693N_(GAC&#x0003e;AAC)</td><td align="center">0.133</td><td align="center">0.19</td><td align="center">0.096</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_033119</td><td align="left">16940</td><td align="center">31</td><td align="center">BRCA1: P_L771L_(TTG&#x0003e;CTG)</td><td align="center">0.422</td><td align="center">0.53</td><td align="center">0.429</td><td align="center">0.012</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_033420</td><td align="left">799917</td><td align="center">32</td><td align="center">BRCA1:P_P871L_(CCG&#x0003e;CTG)</td><td align="center">0.429</td><td align="center">0.51</td><td align="center">0.766</td><td align="center">0.015</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_003927</td><td align="left">4986852</td><td align="center">33</td><td align="center">BRCA1: P_S1040N_(AGC&#x0003e;AAC)</td><td align="center">0.012</td><td align="center">0.02</td><td align="center">0.912</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_034226</td><td align="left">2227945</td><td align="center">34</td><td align="center">BRCA1: P_S1140G_(AGT&#x0003e;GGT)</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_034356</td><td align="left">16942</td><td align="center">35</td><td align="center">BRCA1: P_K1183R_(AAA&#x0003e;AGA)</td><td align="center">0.433</td><td align="center">0.50</td><td align="center">0.868</td><td align="center">0.015</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_7530109</td><td align="left">799916</td><td align="center">36</td><td align="center">BRCA1: intron</td><td align="center">0.438</td><td align="center">0.53</td><td align="center">0.482</td><td align="center">0.015</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_035507</td><td align="left">2070833</td><td align="center">37</td><td align="center">BRCA1: intron</td><td align="center">0.031</td><td align="center">0.04</td><td align="center">0.001</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_036077</td><td align="left">2070834</td><td align="center">38</td><td align="center">BRCA1: intron</td><td align="center">0.435</td><td align="center">0.52</td><td align="center">0.626</td><td align="center">0.014</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_036793</td><td align="left">8176158</td><td align="center">39</td><td align="center">BRCA1: intron</td><td align="center">0.418</td><td align="center">0.54</td><td align="center">0.393</td><td align="center">0.012</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_036859</td><td align="left">8176160</td><td align="center">40</td><td align="center">BRCA1: intron</td><td align="center">0.435</td><td align="center">0.52</td><td align="center">0.626</td><td align="center">0.014</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_038085</td><td align="left">8176166</td><td align="center">41</td><td align="center">BRCA1: intron</td><td align="center">0.196</td><td align="center">0.35</td><td align="center">0.391</td><td align="center">0.018</td><td align="center">0.000</td><td align="center">0.388</td><td align="center">1.000</td></tr><tr><td align="left">BR1_040350</td><td align="left">8176174</td><td align="center">42</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178696</td><td align="left">3950989</td><td align="center">43</td><td align="center">BRCA1: intron</td><td align="center">0.441</td><td align="center">0.52</td><td align="center">0.566</td><td align="center">0.007</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_040669</td><td align="left">8176175</td><td align="center">44</td><td align="center">BRCA1: intron</td><td align="center">0.006</td><td align="center">0.01</td><td align="center">0.956</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_041288</td><td align="left">8176177</td><td align="center">45</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_041721</td><td align="left">8176178</td><td align="center">46</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178676</td><td align="left">1060915</td><td align="center">47</td><td align="center">BRCA1: P_S1436S_(TCT&#x0003e;TCC)</td><td align="center">0.380</td><td align="center">0.56</td><td align="center">0.105</td><td align="center">0.018</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">C_3178677</td><td align="left">3737559</td><td align="center">48</td><td align="center">BRCA1: intron</td><td align="center">0.124</td><td align="center">0.20</td><td align="center">0.481</td><td align="center">0.001</td><td align="center">0.001</td><td align="center">0.462</td><td align="center">1.000</td></tr><tr><td align="left">BR1_045154</td><td align="left">8176187</td><td align="center">49</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_045505</td><td align="left">8176188</td><td align="center">50</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_0046019</td><td align="left">6416927</td><td align="center">51</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_047826</td><td align="left">8176198</td><td align="center">52</td><td align="center">BRCA1: intron</td><td align="center">0.422</td><td align="center">0.53</td><td align="center">0.429</td><td align="center">0.016</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_0477839</td><td align="left">8176199</td><td align="center">53</td><td align="center">BRCA1: intron</td><td align="center">0.341</td><td align="center">0.42</td><td align="center">0.594</td><td align="center">0.016</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_048551</td><td align="left">4239147</td><td align="center">54</td><td align="center">BRCA1: intron</td><td align="center">0.440</td><td align="center">0.52</td><td align="center">0.640</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_050244</td><td align="left">8176206</td><td align="center">55</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_11621042</td><td align="left">2236762</td><td align="center">56</td><td align="center">BRCA1: intron</td><td align="center">0.435</td><td align="center">0.52</td><td align="center">0.626</td><td align="center">0.016</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615208</td><td align="left">1799966</td><td align="center">57</td><td align="center">BRCA1: intron</td><td align="center">0.456</td><td align="center">0.54</td><td align="center">0.456</td><td align="center">0.008</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">0.185</td></tr><tr><td align="left">BR1_055669</td><td align="left">3092987</td><td align="center">58</td><td align="center">BRCA1: intron</td><td align="center">0.416</td><td align="center">0.52</td><td align="center">0.545</td><td align="center">0.013</td><td align="center">0.002</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_056796</td><td align="left">8176225</td><td align="center">59</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_058369</td><td align="left">8176232</td><td align="center">60</td><td align="center">BRCA1: intron</td><td align="center"><underline>0.013</underline></td><td align="center">0.03</td><td align="center">0.936</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_058614</td><td align="left">8176234</td><td align="center">61</td><td align="center">BRCA1: intron</td><td align="center">0.437</td><td align="center">0.54</td><td align="center">0.345</td><td align="center">0.016</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_058834</td><td align="left">8176235</td><td align="center">62</td><td align="center">BRCA1: intron</td><td align="center">0.339</td><td align="center">0.44</td><td align="center">0.872</td><td align="center">0.017</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_059589</td><td align="left">8176236</td><td align="center">63</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_060022</td><td align="left">8176240</td><td align="center">64</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_060520</td><td align="left">8176242</td><td align="center">65</td><td align="center">BRCA1: intron</td><td align="center">0.433</td><td align="center">0.52</td><td align="center">0.538</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_061014</td><td align="left">8176245</td><td align="center">66</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615220</td><td align="left">3092994</td><td align="center">67</td><td align="center">BRCA1: intron</td><td align="center">0.434</td><td align="center">0.53</td><td align="center">0.471</td><td align="center">0.012</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">BR1_062588</td><td align="left">8176259</td><td align="center">68</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_0064398</td><td align="left">8176265</td><td align="center">69</td><td align="center">BRCA1: intron</td><td align="center">0.417</td><td align="center">0.52</td><td align="center">0.477</td><td align="center">0.012</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_064501</td><td align="left">2187603</td><td align="center">70</td><td align="center">BRCA1: intron</td><td align="center">0.422</td><td align="center">0.53</td><td align="center">0.429</td><td align="center">0.009</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_066741</td><td align="left">8176273</td><td align="center">71</td><td align="center">BRCA1: intron</td><td align="center">0.424</td><td align="center">0.52</td><td align="center">0.580</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_067978</td><td align="left">8176278</td><td align="center">72</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_068063</td><td align="left">8066171</td><td align="center">73</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">M_5382insC</td><td align="left">NA</td><td align="center">74</td><td align="center">BRCA1:exon 20</td><td align="center"><underline>0.006</underline></td><td align="center">0.01</td><td align="center">0.957</td><td align="center">0.000</td><td align="center">NA</td><td align="center">1.000</td><td align="center">NA</td></tr><tr><td align="left">C_2615230</td><td align="left">8176289</td><td align="center">75</td><td align="center">BRCA1: intron</td><td align="center">0.441</td><td align="center">0.52</td><td align="center">0.566</td><td align="center">0.014</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_073023</td><td align="left">8176293</td><td align="center">76</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_074008</td><td align="left">4793192</td><td align="center">77</td><td align="center">BRCA1: intron</td><td align="center">0.435</td><td align="center">0.52</td><td align="center">0.626</td><td align="center">0.016</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_074807</td><td align="left">8176296</td><td align="center">78</td><td align="center">BRCA1: intron</td><td align="center">0.435</td><td align="center">0.51</td><td align="center">0.703</td><td align="center">0.015</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615238</td><td align="left">3092988</td><td align="center">79</td><td align="center">BRCA1: intron</td><td align="center">0.424</td><td align="center">0.52</td><td align="center">0.580</td><td align="center">0.015</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_076933</td><td align="left">8176303</td><td align="center">80</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_077034</td><td align="left">8176305</td><td align="center">81</td><td align="center">BRCA1: intron</td><td align="center">0.094</td><td align="center">0.16</td><td align="center">0.753</td><td align="center">0.002</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_077328</td><td align="left">8176307</td><td align="center">82</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_079220</td><td align="left">8068463</td><td align="center">83</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_079396</td><td align="left">8176313</td><td align="center">84</td><td align="center">BRCA1: intron</td><td align="center">0.006</td><td align="center">0.01</td><td align="center">0.957</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_080570</td><td align="left">8176316</td><td align="center">85</td><td align="center">BRCA1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_081125</td><td align="left">8176318</td><td align="center">86</td><td align="center">BRCA1: UTR</td><td align="center">0.435</td><td align="center">0.49</td><td align="center">0.963</td><td align="center">0.009</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_081990</td><td align="left">12516</td><td align="center">87</td><td align="center">BRCA1: UTR</td><td align="center">0.435</td><td align="center">0.52</td><td align="center">0.626</td><td align="center">0.014</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_082035</td><td align="left">8176320</td><td align="center">88</td><td align="center">BRCA1: UTR</td><td align="center">0.006</td><td align="center">0.01</td><td align="center">0.957</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_082199</td><td align="left">8176321</td><td align="center">89</td><td align="center">Intergenic</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">BR1_082687</td><td align="left">8176323</td><td align="center">90</td><td align="center">Intergenic</td><td align="center">0.429</td><td align="center">0.51</td><td align="center">0.766</td><td align="center">0.015</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_11621012</td><td align="left">7223952</td><td align="center">91</td><td align="center">Intergenic</td><td align="center">0.441</td><td align="center">0.52</td><td align="center">0.566</td><td align="center">0.014</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178665</td><td align="left">9911630</td><td align="center">92</td><td align="center">Intergenic</td><td align="center">0.422</td><td align="center">0.53</td><td align="center">0.429</td><td align="center">0.016</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2615245</td><td align="left">11460963</td><td align="center">93</td><td align="center">Intergenic</td><td align="center">0.441</td><td align="center">0.53</td><td align="center">0.497</td><td align="center">0.014</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178699</td><td align="left">2298861</td><td align="center">94</td><td align="center">ARHN: locus</td><td align="center">0.441</td><td align="center">0.55</td><td align="center">0.309</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">0.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3178698</td><td align="left">2298862</td><td align="center">95</td><td align="center">ARHN: locus</td><td align="center">0.447</td><td align="center">0.54</td><td align="center">0.383</td><td align="center">0.011</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2287905</td><td align="left">443759</td><td align="center">96</td><td align="center">IFI35:intron</td><td align="center">0.229</td><td align="center">0.41</td><td align="center">0.129</td><td align="center">0.040</td><td align="center">0.002</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_11617231</td><td align="left">11871636</td><td align="center">97</td><td align="center">RPL27: intron</td><td align="center">0.235</td><td align="center">0.40</td><td align="center">0.304</td><td align="center">0.036</td><td align="center">0.002</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1588447</td><td align="left">2271539</td><td align="center">98</td><td align="center">RPL27: intron</td><td align="center">0.388</td><td align="center">0.47</td><td align="center">0.932</td><td align="center">0.023</td><td align="center">0.003</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_765227</td><td align="left">690971</td><td align="center">99</td><td align="center">MGC2744: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1588417</td><td align="left">528854</td><td align="center">100</td><td align="center">MGC2744: intergenic</td><td align="center">0.106</td><td align="center">0.16</td><td align="center">0.230</td><td align="center">0.000</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1588405</td><td align="left">323495</td><td align="center">101</td><td align="center">G6PC: intergenic</td><td align="center">0.316</td><td align="center">0.37</td><td align="center">0.182</td><td align="center">0.004</td><td align="center">0.000</td><td align="center">0.205</td><td align="center">1.000</td></tr><tr><td align="left">C_3256885</td><td align="left">2593595</td><td align="center">102</td><td align="center">G6PC: intron</td><td align="center">0.124</td><td align="center">0.15</td><td align="center">0.007</td><td align="center">0.000</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3256881</td><td align="left">324075</td><td align="center">103</td><td align="center">Intergenic</td><td align="center">0.171</td><td align="center">0.29</td><td align="center">0.717</td><td align="center">0.000</td><td align="center">0.000</td><td align="center">0.266</td><td align="center">1.000</td></tr><tr><td align="left">C_15883310</td><td align="left">2290041</td><td align="center">104</td><td align="center">PRKWNK4: mis-sense</td><td align="center">0.012</td><td align="center">0.02</td><td align="center">0.913</td><td align="center">0.005</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_2160077</td><td align="left">4321242</td><td align="center">105</td><td align="center">RAMP2: intron</td><td align="center">0.480</td><td align="center">0.58</td><td align="center">0.158</td><td align="center">0.003</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1075621</td><td align="left">752313</td><td align="center">106</td><td align="center">EZH1: intergenic</td><td align="center">0.363</td><td align="center">0.40</td><td align="center">0.314</td><td align="center">0.005</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_3256867</td><td align="left">7359598</td><td align="center">107</td><td align="center">EZH1: intergenic</td><td align="center">0.386</td><td align="center">0.57</td><td align="center">0.073</td><td align="center">0.005</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">0.000</td></tr><tr><td align="left">C_15959277</td><td align="left">2271027</td><td align="center">108</td><td align="center">EZH1: intron</td><td align="center">0.000</td><td></td><td></td><td></td><td></td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1441435</td><td align="left">7214055</td><td align="center">109</td><td align="center">CNTNAP1: UTR</td><td align="center">0.149</td><td align="center">0.30</td><td align="center">0.109</td><td align="center">0.001</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1441436</td><td align="left">9766</td><td align="center">110</td><td align="center">CNTNAP1: UTR</td><td align="center">0.353</td><td align="center">0.52</td><td align="center">0.219</td><td align="center">0.007</td><td align="center">0.000</td><td align="center">0.173</td><td align="center">1.000</td></tr><tr><td align="left">C_7529639</td><td align="left">1553469</td><td align="center">111</td><td align="center">CNTNAP1: silent</td><td align="center">0.065</td><td align="center">0.11</td><td align="center">0.248</td><td align="center">0.002</td><td align="center">0.000</td><td align="center">0.463</td><td align="center">1.000</td></tr><tr><td align="left">C_1125369</td><td align="left">2271029</td><td align="center">112</td><td align="center">CNTNAP1: silent</td><td align="center">0.405</td><td align="center">0.62</td><td align="center">0.009</td><td align="center">0.000</td><td align="center">0.001</td><td align="center">0.040</td><td align="center">1.000</td></tr><tr><td align="left">C_1441438</td><td align="left">3760384</td><td align="center">113</td><td align="center">CNTNAP1: intron</td><td align="center">0.359</td><td align="center">0.58</td><td align="center">0.020</td><td align="center">0.005</td><td align="center">0.000</td><td align="center">1.000</td><td align="center">1.000</td></tr><tr><td align="left">C_1441444</td><td align="left">2292749</td><td align="center">114</td><td align="center">TUBG2: intron</td><td align="center">0.217</td><td align="center">0.39</td><td align="center">0.219</td><td align="center">0.006</td><td align="center">0.001</td><td align="center">1.000</td><td align="center">1.000</td></tr></tbody></table><table-wrap-foot><p><sup>a </sup>maf = Minor allele frequency</p><p><sup>b</sup>Het = Heterozygosity</p><p><sup>c</sup>Population private SNPs are shown underlined</p><p><sup>d</sup>NA= Not Applicable</p></table-wrap-foot></table-wrap><p>Haplotypes were estimated for the set of all SNPs with MAF &#x02265; 0.05. Haplotypes for the founder mutation containing chromosomes were unambiguously determined in at least one family across the entire region studied. The185delAG and 5382insC mutations occurred on the two most common haplotypes, representing 15% (haplotype 2) and 29% (haplotype 1) of the chromosomes, respectively, among Ashkenazi Jews (Fig. <xref ref-type="fig" rid="F3">3D</xref>). In the haplotype analyses, the 185delAG mutation occurred on a chromosome with the minor allele at most loci, and the 5382insC on a chromosome with the major allele at most loci (Fig. <xref ref-type="fig" rid="F3">3D</xref>). This pattern constitutes what has been previously described as "yin yang haplotypes", in which two high-frequency haplotypes have different alleles at most SNP sites [<xref ref-type="bibr" rid="B33">33</xref>].</p></sec></sec><sec><title>Discussion</title><p>The primary objective of this study was to address the question of whether we could identify the Ashkenazi <italic>BRCA1 </italic>founder mutation 185delAG in a typical case-control association study, using anonymous genetic markers. The answer is no. The impact on the required sample size (S) needed if one studies a marker in LD with the true disease allele is related to the inverse of the square of their correlation coefficient (<italic>r</italic>), as in S = 1/<italic>r</italic><sup>2 </sup>[<xref ref-type="bibr" rid="B34">34</xref>]. Almost none of the SNPs had a high correlation coefficient with either founder mutation (Table <xref ref-type="table" rid="T2">2</xref>). Since most markers were more common than the founder mutations, this result is not surprising. However, our SNP selection strategy did not exclude low frequency SNPs. In fact, one of the SNPs identified in 3 of the 90 Polymorphism Discovery Resource subjects [<xref ref-type="bibr" rid="B35">35</xref>] was perfectly correlated with 5382insC. However, we did not observe this SNP in any of the four non-Ashkenazi reference populations. Based on our results, the sample size required to detect the 185delAG mutation in a breast cancer case-control study conducted in Ashkenazi women that did not directly test for the mutation, would be at least 25 times larger than one that measured the mutation directly, requiring on the order of 62,000 subjects. Based on pair-wise measurements, we conclude that it would have been extremely difficult to have mapped the two founder mutations using the case-control association methodology using common SNPs.</p><p>Association studies may also compare combinations of SNPs, or haplotypes, between cases and controls, and the founder mutations might have been discoverable if they occurred on uncommon haplotypes. Using relatively common SNPs (MAF &#x02265; 5%), like those on whole-genome SNP platforms, we found that the two mutations were present on haplotypes representing a polar pattern, termed yin-yang haplotypes [<xref ref-type="bibr" rid="B33">33</xref>]. These two haplotypes accounted together for a large percentage of the total chromosomes studied, independent of the population, ranging from 64% for the Chinese-Americans to 43% for the CEPH.</p><p>It is highly unlikely that the founder mutations could have been discovered owing to a difference in haplotype frequency between cases and controls largely because they occur on the two most common haplotypes. For example, consider a case-control study of Ashkenazi Jews with 500 cases and 500 controls. Among controls (1000 chromosomes), the distribution of <italic>BRCA1</italic>-containing haplotypes would be roughly as in Fig. <xref ref-type="fig" rid="F3">3D</xref> (i.e., there would have been 288 chromosomes with haplotype 1 and 153 with haplotype 2). Among cases, assuming 1% carried 5382insC and 4% carried 185delAG, there would be 5 additional haplotype 1 (total = 293) and 20 additional haplotype 2 (total = 173) chromosomes. These case-control contrasts, 293 vs. 288 (OR 1.02) and 173 vs. 153, would require extremely large sample sizes of over 30,000 subjects to detect either mutation with 80% statistical power. Conversely, in the more advantageous situation in which the 185delAG mutation by chance occurred on a rare haplotype (for example, haplotype 8), there would have been 32 such chromosomes in cases vs. 12 in controls requiring approximately 4,800 subjects for the same statistical power.</p><p>The <italic>BRCA1 </italic>locus is well known to have significant LD [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Nonetheless, we found a marked differentiation between African-Americans and non-African Americans in the haplotype block analysis. Compared with African-Americans, the non-African American populations had less haplotype diversity and more extensive LD (Fig. <xref ref-type="fig" rid="F1">1</xref>). The increased number of crossovers along the entire region for African-Americans probably reflects older evolutionary events. Our data conform to previous findings [<xref ref-type="bibr" rid="B27">27</xref>], describing higher haplotype diversity as well as less extensive LD in the Yoruban and African American samples than in European and Asian populations. When SNP "bins" derived from pair-wise measurements of LD were compared, we found a greater extent of LD boundaries being shared across the five different ethnical groups (Fig. <xref ref-type="fig" rid="F2">2</xref>). Ashkenazi Jews and the CEPH population had highly similar patterns of LD, independently of the type of analysis used to generate the LD structures (haplotype, or pair-wise bin methods) (Fig. <xref ref-type="fig" rid="F1">1</xref> and Fig. <xref ref-type="fig" rid="F2">2</xref>). Overall, haplotype blocks and bins showed similar patterns, probably owing to the strong LD present overall in this region. The LDU analysis showed a remarkable overall similarity with the two previous methods that were used to analyze LD (Fig. <xref ref-type="fig" rid="F4">4</xref>). There were basically four major breakdowns in LD downstream to <italic>BRCA1 </italic>that were largely shared across populations. Nevertheless, African-Americans presented more recombination events than the other four populations, consistent with the smaller block sizes showed in Fig. <xref ref-type="fig" rid="F1">1</xref>.</p></sec><sec><title>Conclusion</title><p>In summary, our detailed analyses of 114 polymorphic SNPs in a 646 kb region around <italic>BRCA1 </italic>in Ashkenazi Jews and other populations confirmed a high level of linkage disequilibrium across nearly the entire region. In addition to 85 unrelated Ashkenazi Jews, we over-sampled carriers of the founder mutations 185delAG and 5382insC and their relatives to more precisely calculate correlations with other markers and to molecularly determine the mutation associated haplotypes (these subjects were not included in allele frequency estimates). This allowed us to assess the likelihood of discovering the founder mutations by virtue of their association with individual SNPs or haplotypes that one would assay in a breast cancer case-control study in Ashkenazi Jews. We did not observe a high correlation coefficient between any individual SNP likely to be included in a genome-wide anonymous scan and either founder mutation. Our findings suggest that a study at least 25X larger (60,000 subjects or more) would have been required if the mutations were not tested for directly. The two founder mutations occur on the two most common haplotypes, representing over 40% of the chromosomes, also suggesting that a haplotype-based analysis would not have been successful at detecting either of the underlying mutations. These results are influenced heavily by the relative rarity of the founder mutations, as reflected by high values for Lewontin's D' measures of LD but low correlation coefficients. Our results suggest caution in using genome-wide association studies with common SNPs for detecting uncommon, disease-causing mutations.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>Independent subjects included 85 unrelated Ashkenazi Jews, 60 European-Americans (Utah) from the CEPH (The Centre d'Etude du Polymorphisme Humain) family collection, and 48 each from African-Americans, Chinese-Americans and Mexican-Americans (Human Diversity Collection, Coriell Cell Repository, Camden, NJ). The 30 children of the 60 Utah CEPH subjects were also assayed to test for Mendelian errors. In addition, six unrelated <italic>BRCA1</italic>:185delAG and three unrelated <italic>BRCA1</italic>:5382insC founder mutation carriers and their relatives [<xref ref-type="bibr" rid="B36">36</xref>], identified through the National Cancer Institute's Cancer Family Registry, were included in the study in order to establish mutation-associated haplotypes from family data. Mutation-associated haplotypes were inferred through inspection of genotypes for all available first-degree relatives of mutation carriers. The Ashkenazi Jewish samples were obtained from anonymous control subjects from the National Laboratory for the Genetics of Israeli Populations at Tel-Aviv University [<xref ref-type="bibr" rid="B37">37</xref>].</p></sec><sec><title>Marker selection and genotyping</title><p>The 90 kb <italic>BRCA1 </italic>locus was previously re-sequenced in 90 individuals representing five major US ethnic/population groups from the Polymorphism Discovery Resource (PDR-90) [<xref ref-type="bibr" rid="B35">35</xref>], by the University of Washington as part of the Environmental Genome Project (EGP) [<xref ref-type="bibr" rid="B38">38</xref>]. Samples consisted of 24 European-, 24 African- 24 Asian-, 12 Mexican-, and six Native-Americans. The geographic origin of individual donors, however, is masked and may not be used to assign allele frequencies to specific sub-populations. Most of the 301 variants identified were SNPs. Genotyping all 301 variants at this locus in the current study was not necessary since many are highly correlated. We developed the following strategy to identify a reduced set of variants that still captured much of the diversity of the region. Using the EGP data on all 299 biallelic single nucleotide substitutions (i.e., no lower minor allele frequency cutoff), and using custom software, we calculated all pair-wise correlations (<italic>r</italic><sup>2</sup>) and created "clusters", defined as groups of SNPs that were perfectly correlated with all others in the cluster. Our method is similar to LDSelect 1.0 [<xref ref-type="bibr" rid="B28">28</xref>] except that it required that all pair-wise correlations of SNPs in a cluster be 1.0 (i.e., complete LD). LDSelect is typically used with a threshold value of <italic>r</italic><sup>2 </sup>of 0.8, and SNPs are clustered into "LD bins" if their pair-wise <italic>r</italic><sup>2 </sup>is at or above this threshold value with at least one other SNP (but not all) in the bin. Using an <italic>r</italic><sup>2 </sup>of 1.0 resulted in more clusters than a lower <italic>r</italic><sup>2 </sup>threshold, increasing the number of SNPs assayed in this study.</p><p>Taqman 5'-nuclease assays were developed through Applied Biosystems (Foster City, CA) Assay-by-Design service after first filtering for repetitive, non-unique, and low-complexity sequence. We developed assays for all "singleton" SNPs (those that did not have pair-wise <italic>r</italic><sup>2 </sup>values of 1.0 with another SNP). For the 59 clusters with two or more SNPs, we chose one SNP from each cluster of two, three and four SNPs, and for 9 clusters of five or more SNPs, we chose one fourth of them for assay development. In addition, we selected all (<italic>n </italic>= 43) commercially available Assay-on-Demand assays (Applied Biosystems, Foster City, CA) that mapped within approximately 200 kb upstream and 400 kb downstream of the <italic>BRCA1 </italic>locus. This SNP set represented almost all known variants (or ones highly correlated) at this locus.</p><p>Of the 143 resulting assays, three were excluded due to technical problems (poor clustering or more than one Mendelian error), and 28 were not polymorphic in our complete sample set, leaving 112 polymorphic SNPs in addition to the two founder mutations. There were 82 <italic>BRCA1 </italic>intragenic SNPs (approximately one SNP per 1 kb) and 30 SNPs that mapped to the region outside <italic>BRCA1 </italic>(approximately one SNP per 20 kb). The allelic discrimination assays were performed in 5 microliter reactions in 384-well plates according to manufacturer's recommendations. Data were analyzed with the allelic discrimination SDS 2.1 software on an ABI 7900HT (Applied Biosystems, Foster City, CA), with manual determination of genotype clusters [see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>].</p></sec><sec><title>Statistical analysis</title><p>Allelic frequency and chi-square goodness-of-fit tests for Hardy-Weinberg equilibrium (HWE) were calculated using SAS/Genetics 9.1 (SAS Institute, Inc., Cary, North Carolina). To assess the correlation between the two founder mutations and all other SNPs, we over-sampled mutation carriers and calculated a weighted Pearson's correlation coefficient using SAS 9.1. We also tested association by use of Tagger [<xref ref-type="bibr" rid="B39">39</xref>] operates in either pairwise or aggressive mode, and we used both approaches to examine association. Heterozygosity levels, as well as the variation in gene frequencies between populations by means of their F<sub>ST </sub>(Wright's <italic>F</italic>-statistics) were calculated using POPGENE 1.31 [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>Haplotypes and their frequencies were inferred from genotypes across the entire region for each population separately, using the software package SNPHAP 1.3 [<xref ref-type="bibr" rid="B41">41</xref>], as implemented in Hapscope [<xref ref-type="bibr" rid="B42">42</xref>], for loci with minor allele frequencies (MAF) &#x0003e; 5%. SNPHAP uses the expectation-maximization algorithm to calculate maximum likelihood estimates of haplotype frequencies from unphased genotype data.</p><p>In order to compare LD patterns across different populations, we employed two different analyses, the first based on partitioning SNPs into haplotype blocks [<xref ref-type="bibr" rid="B27">27</xref>] using Haploview [<xref ref-type="bibr" rid="B43">43</xref>] and the second based on "bins" of correlated SNPs not constrained to be adjacent to each other [<xref ref-type="bibr" rid="B28">28</xref>]. The binning method used a modified version of LDSelect 1.0 that calculates composite LD measures [<xref ref-type="bibr" rid="B44">44</xref>], without assuming that loci are in Hardy-Weinberg equilibrium. We used an <italic>r</italic><sup>2 </sup>threshold of 0.8 for binning SNPs, and filtered SNPs with population-specific MAF &#x02264; 0.05.</p><p>LDSelect identifies tagSNPs, representing those SNPs in a bin that have <italic>r</italic><sup>2 </sup>values at or above the threshold with all other SNPs in a bin. Only one tagSNP in each bin needs to be assayed to capture the majority of the SNP diversity. The block method employed by Haploview groups adjacent SNPs in strong LD, defined as those with one-sided upper 95% confidence bound on D' &#x0003e;0.98 and the lower bound &#x0003e;0.7. In this method, haplotype tag SNPs (htSNPs) represents the set of SNPs that must be assayed in each block to capture all haplotypes at 1% frequency in the population.</p><p>LD maps were constructed from genotype data with the software LDMAP [<xref ref-type="bibr" rid="B45">45</xref>]. LD maps are scaled in linkage disequilibrium units (LDU) and show (when plotted against the physical map) a pattern of plateaus (reflecting regions of low haplotype diversity and low recombination) and steps (representing regions of historical recombination events).</p><p>We genotyped related individuals from families segregating 185delAG and 5382insC founder mutations in order to reconstruct their haplotypes. The 185delAG- and 5382insC-containing haplotypes were unambiguously determined from analyzing the genotypes of all available family members. The frequencies of these mutation-containing haplotypes were determined from SNPHAP analyses of the five populations separately. Block boundaries were defined based on Haploview analyses and overlaid upon the SNPHAP results.</p><p>We estimated the required number of subjects to have 80% statistical power to identify the 185delAG mutation if tested directly in a case-control study to be approximately 2492 using EpiInfo 4.0 [<xref ref-type="bibr" rid="B46">46</xref>], assuming equal numbers of cases and controls, alpha of 0.0001, and heterozygous carrier frequencies of 0.6% for controls and 3.3% for cases.</p></sec></sec><sec><title>Competing interests</title><p>The author(s) declares that there are no competing interests.</p></sec><sec><title>Authors' contributions</title><p>LMP performed laboratory and statistical analysis and drafted the manuscript. MAP and LRF performed laboratory analysis. WHR and JZ wrote custom software and performed statistical analysis. MHG provided biomaterials and critically revised the manuscript. KO and NAE participated in the study design and analysis. AC provided design assistance and performed statistical analysis. JPS conceived and designed the study and performed statistical analysis. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>Summary of F-statistics and heterozygosity for all loci. Heterozygosity levels, as well as the variation in gene frequencies between populations by means of their F<sub>ST </sub>(Wright's F-statistics).</p></caption><media xlink:href="1471-2156-8-68-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p>Genotypes for all 114 polymorphic SNPs in 5 populations. Raw genotypes. Populations: (1) CEPH (includes related individuals), (2) African Americans, (3) Chinese Americans, (4) Mexican Americans and (5) Ashkenazi Jews.</p></caption><media xlink:href="1471-2156-8-68-S2.txt" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>This research was supported in part by the Intramural Research Program of the NIH, Center for Cancer Research and the Division of Cancer Epidemiology and Genetics, National Cancer Institute, U.S. Department of Health and Human Services.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>Y</given-names></name><name><surname>Swensen</surname><given-names>J</given-names></name><name><surname>Shattuck-Eidens</surname><given-names>D</given-names></name><name><surname>Futreal</surname><given-names>PA</given-names></name><name><surname>Harshman</surname><given-names>K</given-names></name><name><surname>Tavtigian</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Cochran</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>LM</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Bell</surname><given-names>R</given-names></name><name><surname>Rosenthal</surname><given-names>J</given-names></name><name><surname>Hussey</surname><given-names>C</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>McClure</surname><given-names>M</given-names></name><name><surname>Frye</surname><given-names>C</given-names></name><name><surname>Hattier</surname><given-names>T</given-names></name><name><surname>Phrlps</surname><given-names>R</given-names></name><name><surname>Haugen-Strano</surname><given-names>A</given-names></name><name><surname>Katcher</surname><given-names>H</given-names></name><name><surname>Yakumo</surname><given-names>K</given-names></name><name><surname>Gholami</surname><given-names>Z</given-names></name><name><surname>Shaffer</surname><given-names>D</given-names></name><name><surname>Stone</surname><given-names>D</given-names></name><name><surname>Bayer</surname><given-names>S</given-names></name><name><surname>Wray</surname><given-names>C</given-names></name><name><surname>Bogden</surname><given-names>R</given-names></name><name><surname>Dayanath</surname><given-names>P</given-names></name><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Tonin</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>A strong candidate for the breast and ovarian cancer susceptibility gene <italic>BRCA1</italic></article-title><source>Science</source><year>1994</year><volume>266</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">7545954</pub-id><pub-id pub-id-type="doi">10.1126/science.7545954</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wooster</surname><given-names>R</given-names></name><name><surname>Bignell</surname><given-names>G</given-names></name><name><surname>Lancaster</surname><given-names>J</given-names></name><name><surname>Swift</surname><given-names>S</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Mangion</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>N</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Gumbs</surname><given-names>C</given-names></name><name><surname>Micklem</surname><given-names>G</given-names></name></person-group><article-title>Identification of the breast cancer susceptibility gene <italic>BRCA2</italic></article-title><source>Nature</source><year>1995</year><volume>378</volume><fpage>789</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">8524414</pub-id><pub-id pub-id-type="doi">10.1038/378789a0</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>CI</given-names></name><name><surname>King</surname><given-names>MC</given-names></name></person-group><article-title>Population genetics of <italic>BRCA1 </italic>and <italic>BRCA2</italic></article-title><source>Am J Hum Genet</source><year>1997</year><volume>60</volume><fpage>1013</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">9150148</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tonin</surname><given-names>P</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name><name><surname>Offit</surname><given-names>K</given-names></name><name><surname>Couch</surname><given-names>F</given-names></name><name><surname>Rebbeck</surname><given-names>TR</given-names></name><name><surname>Neuhausen</surname><given-names>S</given-names></name><name><surname>Godwin</surname><given-names>AK</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><name><surname>Wagner-Costalos</surname><given-names>J</given-names></name><name><surname>Berman</surname><given-names>D</given-names></name><name><surname>Grana</surname><given-names>G</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Kane</surname><given-names>MF</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name><name><surname>Krainer</surname><given-names>M</given-names></name><name><surname>Haber</surname><given-names>DA</given-names></name><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Warner</surname><given-names>E</given-names></name><name><surname>Rosen</surname><given-names>B</given-names></name><name><surname>Lerman</surname><given-names>C</given-names></name><name><surname>Peshkin</surname><given-names>B</given-names></name><name><surname>Norton</surname><given-names>L</given-names></name><name><surname>Serova</surname><given-names>O</given-names></name><name><surname>Foulkes</surname><given-names>WD</given-names></name><name><surname>Lynch</surname><given-names>HT</given-names></name><name><surname>Lenoir</surname><given-names>GM</given-names></name><name><surname>Narod</surname><given-names>SA</given-names></name><name><surname>Garber</surname><given-names>JE</given-names></name></person-group><article-title>Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>1179</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">8898735</pub-id><pub-id pub-id-type="doi">10.1038/nm1196-1179</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>A</given-names></name><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>Narod</surname><given-names>S</given-names></name><name><surname>Risch</surname><given-names>HA</given-names></name><name><surname>Eyfjord</surname><given-names>JE</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Loman</surname><given-names>N</given-names></name><name><surname>Olsson</surname><given-names>H</given-names></name><name><surname>Johannsson</surname><given-names>O</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><name><surname>Pasini</surname><given-names>B</given-names></name><name><surname>Radice</surname><given-names>P</given-names></name><name><surname>Manoukian</surname><given-names>S</given-names></name><name><surname>Eccles</surname><given-names>DM</given-names></name><name><surname>Tang</surname><given-names>N</given-names></name><name><surname>Olah</surname><given-names>E</given-names></name><name><surname>Anton-Culver</surname><given-names>H</given-names></name><name><surname>Warner</surname><given-names>E</given-names></name><name><surname>Lubinski</surname><given-names>J</given-names></name><name><surname>Gronwald</surname><given-names>J</given-names></name><name><surname>Gorski</surname><given-names>B</given-names></name><name><surname>Tulinius</surname><given-names>H</given-names></name><name><surname>Thorlacius</surname><given-names>S</given-names></name><name><surname>Eerola</surname><given-names>H</given-names></name><name><surname>Nevanlinna</surname><given-names>H</given-names></name><name><surname>Syrjakoski</surname><given-names>K</given-names></name><name><surname>Kallioniemi</surname><given-names>OP</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Evans</surname><given-names>C</given-names></name><name><surname>Peto</surname><given-names>J</given-names></name><name><surname>Lalloo</surname><given-names>F</given-names></name><name><surname>Evans</surname><given-names>DG</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name></person-group><article-title>Average risks of breast and ovarian cancer associated with <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutations detected in case Series unselected for family history: a combined analysis of 22 studies</article-title><source>Am J Hum Genet</source><year>2003</year><volume>72</volume><fpage>1117</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">12677558</pub-id><pub-id pub-id-type="doi">10.1086/375033</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Easton</surname><given-names>D</given-names></name><name><surname>McGuffog</surname><given-names>L</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Dunning</surname><given-names>A</given-names></name><name><surname>Tee</surname><given-names>L</given-names></name><name><surname>Baynes</surname><given-names>C</given-names></name><name><surname>Healey</surname><given-names>C</given-names></name><name><surname>Pharoah</surname><given-names>P</given-names></name><name><surname>Ponder</surname><given-names>B</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Sodha</surname><given-names>N</given-names></name><name><surname>Eeles</surname><given-names>R</given-names></name><name><surname>Stratton</surname><given-names>M</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Peto</surname><given-names>J</given-names></name><name><surname>Spurdle</surname><given-names>AB</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chenevix-Trench</surname><given-names>G</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name><name><surname>McCredie</surname><given-names>MRE</given-names></name><name><surname>Holli</surname><given-names>KSK</given-names></name><name><surname>Kallioniemi</surname><given-names>O</given-names></name><name><surname>Eerola</surname><given-names>H</given-names></name><name><surname>Vahteristo</surname><given-names>P</given-names></name><name><surname>Blomqvist</surname><given-names>C</given-names></name><name><surname>Nevanlinna</surname><given-names>H</given-names></name><name><surname>Kataja</surname><given-names>V</given-names></name><name><surname>Mannermaa</surname><given-names>A</given-names></name><etal></etal></person-group><article-title><italic>CHEK2</italic>*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies</article-title><source>Am J Hum Genet</source><year>2004</year><volume>74</volume><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">15122511</pub-id><pub-id pub-id-type="doi">10.1086/421251</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renwick</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name><name><surname>Chagtai</surname><given-names>T</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>North</surname><given-names>B</given-names></name><name><surname>Jayatilake</surname><given-names>H</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Spanova</surname><given-names>K</given-names></name><name><surname>McGuffog</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>DG</given-names></name><name><surname>Eccles</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name></person-group><article-title><italic>ATM </italic>mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>873</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">16832357</pub-id><pub-id pub-id-type="doi">10.1038/ng1837</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Renwick</surname><given-names>A</given-names></name><name><surname>Elliott</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Chagtai</surname><given-names>T</given-names></name><name><surname>Jayatilake</surname><given-names>H</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Spanova</surname><given-names>K</given-names></name><name><surname>North</surname><given-names>B</given-names></name><name><surname>McGuffog</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>DG</given-names></name><name><surname>Eccles</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name></person-group><article-title>Truncating mutations in the Fanconi anemia J gene <italic>BRIP1 </italic>are low-penetrance breast cancer susceptibility alleles</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1239</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">17033622</pub-id><pub-id pub-id-type="doi">10.1038/ng1902</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name><name><surname>Renwick</surname><given-names>A</given-names></name><name><surname>Elliott</surname><given-names>A</given-names></name><name><surname>Reid</surname><given-names>S</given-names></name><name><surname>Spanova</surname><given-names>K</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Chagtai</surname><given-names>T</given-names></name><name><surname>Jayatilake</surname><given-names>H</given-names></name><name><surname>McGuffog</surname><given-names>L</given-names></name><name><surname>Hanks</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>DG</given-names></name><name><surname>Eccles</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name></person-group><article-title><italic>PALB2</italic>, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>165</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">17200668</pub-id><pub-id pub-id-type="doi">10.1038/ng1959</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Dunning</surname><given-names>AM</given-names></name><name><surname>Garcia-Closas</surname><given-names>M</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Reed</surname><given-names>MW</given-names></name><name><surname>Pooley</surname><given-names>KA</given-names></name><name><surname>Scollen</surname><given-names>S</given-names></name><name><surname>Baynes</surname><given-names>C</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name><name><surname>Chanock</surname><given-names>S</given-names></name><name><surname>Lissowska</surname><given-names>J</given-names></name><name><surname>Brinton</surname><given-names>L</given-names></name><name><surname>Peplonska</surname><given-names>B</given-names></name><name><surname>Southey</surname><given-names>MC</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>McCredie</surname><given-names>MR</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name><name><surname>Fletcher</surname><given-names>O</given-names></name><name><surname>Johnson</surname><given-names>N</given-names></name><name><surname>dos Santos Silva</surname><given-names>I</given-names></name><name><surname>Gibson</surname><given-names>L</given-names></name><name><surname>Bojesen</surname><given-names>SE</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Axelsson</surname><given-names>CK</given-names></name><name><surname>Torres</surname><given-names>D</given-names></name><name><surname>Hamann</surname><given-names>U</given-names></name><name><surname>Justenhoven</surname><given-names>C</given-names></name><name><surname>Brauch</surname><given-names>H</given-names></name><name><surname>Chang-Claude</surname><given-names>J</given-names></name><name><surname>Kropp</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>A common coding variant in <italic>CASP8 </italic>is associated with breast cancer risk</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>352</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">17293864</pub-id><pub-id pub-id-type="doi">10.1038/ng1981</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemminki</surname><given-names>K</given-names></name><name><surname>Granstrom</surname><given-names>C</given-names></name><name><surname>Czene</surname><given-names>K</given-names></name></person-group><article-title>Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden</article-title><source>Int J Cancer</source><year>2002</year><volume>100</volume><fpage>214</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">12115572</pub-id><pub-id pub-id-type="doi">10.1002/ijc.10467</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemminki</surname><given-names>K</given-names></name><name><surname>Czene</surname><given-names>K</given-names></name></person-group><article-title>Attributable risks of familial cancer from the Family-Cancer Database</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2002</year><volume>11</volume><fpage>1638</fpage><lpage>1644</lpage><pub-id pub-id-type="pmid">12496055</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>NV</given-names></name><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Iliadou</surname><given-names>A</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Skytthe</surname><given-names>A</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Environmental and heritable factors in the causation of cancer &#x02013; analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">10891514</pub-id><pub-id pub-id-type="doi">10.1056/NEJM200007133430201</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N</given-names></name></person-group><article-title>The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2001</year><volume>10</volume><fpage>733</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">11440958</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peto</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>N</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Warren</surname><given-names>W</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Evans</surname><given-names>C</given-names></name><name><surname>Deacon</surname><given-names>J</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name></person-group><article-title>Prevalence of <italic>BRCA1 </italic>and <italic>BRCA2 </italic>gene mutations in patients with early-onset breast cancer</article-title><source>J Natl Cancer Inst</source><year>1999</year><volume>91</volume><fpage>943</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">10359546</pub-id><pub-id pub-id-type="doi">10.1093/jnci/91.11.943</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>AC</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name></person-group><article-title>Polygenic inheritance of breast cancer: Implications for design of association studies</article-title><source>Genet Epidemiol</source><year>2003</year><volume>25</volume><fpage>190</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">14557987</pub-id><pub-id pub-id-type="doi">10.1002/gepi.10261</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><article-title>A haplotype map of the human genome</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>1299</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">16255080</pub-id><pub-id pub-id-type="doi">10.1038/nature04226</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N</given-names></name><name><surname>Merikangas</surname><given-names>K</given-names></name></person-group><article-title>The future of genetic studies of complex human diseases</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>1516</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">8801636</pub-id><pub-id pub-id-type="doi">10.1126/science.273.5281.1516</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>Dunning</surname><given-names>AM</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name></person-group><article-title>Association studies for finding cancer-susceptibility genetic variants</article-title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><fpage>850</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">15516958</pub-id><pub-id pub-id-type="doi">10.1038/nrc1476</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Genome-wide association studies for common diseases and complex traits</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><fpage>95</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">15716906</pub-id><pub-id pub-id-type="doi">10.1038/nrg1521</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Pooley</surname><given-names>KA</given-names></name><name><surname>Dunning</surname><given-names>AM</given-names></name><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Ballinger</surname><given-names>DG</given-names></name><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Morrison</surname><given-names>J</given-names></name><name><surname>Field</surname><given-names>H</given-names></name><name><surname>Luben</surname><given-names>R</given-names></name><name><surname>Wareham</surname><given-names>N</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Healey</surname><given-names>CS</given-names></name><name><surname>Bowman</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Kolonel</surname><given-names>LK</given-names></name><name><surname>Henderson</surname><given-names>BE</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Sangrajrang</surname><given-names>S</given-names></name><name><surname>Gaborieau</surname><given-names>V</given-names></name><name><surname>Odefrey</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>CY</given-names></name><name><surname>Wu</surname><given-names>PE</given-names></name><name><surname>Wang</surname><given-names>HC</given-names></name><name><surname>Eccles</surname><given-names>D</given-names></name><name><surname>Evans</surname><given-names>DG</given-names></name><name><surname>Peto</surname><given-names>J</given-names></name><name><surname>Fletcher</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>Genome-wide association study identifies novel breast cancer susceptibility loci</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>1087</fpage><lpage>1093</lpage><pub-id pub-id-type="pmid">17529967</pub-id><pub-id pub-id-type="doi">10.1038/nature05887</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><collab>The Wellcome Trust Case Control Consortium</collab></person-group><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>661</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">17554300</pub-id><pub-id pub-id-type="doi">10.1038/nature05911</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>Antoniou</surname><given-names>A</given-names></name><name><surname>Bobrow</surname><given-names>M</given-names></name><name><surname>Zimmern</surname><given-names>RL</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name></person-group><article-title>Polygenic susceptibility to breast cancer and implications for prevention</article-title><source>Nat Genet</source><year>2002</year><volume>31</volume><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">11984562</pub-id><pub-id pub-id-type="doi">10.1038/ng853</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>AC</given-names></name><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>McMullan</surname><given-names>G</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Peto</surname><given-names>J</given-names></name><name><surname>Ponder</surname><given-names>BJ</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name></person-group><article-title>A comprehensive model for familial breast cancer incorporating <italic>BRCA1</italic>, <italic>BRCA2 </italic>and other genes</article-title><source>Br J Cancer</source><year>2002</year><volume>86</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11857015</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6600008</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Brody</surname><given-names>LC</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Kase</surname><given-names>RG</given-names></name><name><surname>Giambarresi</surname><given-names>TR</given-names></name><name><surname>Smith</surname><given-names>SA</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Tucker</surname><given-names>MA</given-names></name></person-group><article-title>Detection of eight <italic>BRCA1 </italic>mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer</article-title><source>Am J Hum Genet</source><year>1995</year><volume>57</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7611277</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Abeliovich</surname><given-names>D</given-names></name><name><surname>Peretz</surname><given-names>T</given-names></name><name><surname>Avishai</surname><given-names>N</given-names></name><name><surname>Kaback</surname><given-names>MM</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Brody</surname><given-names>LC</given-names></name></person-group><article-title>The carrier frequency of the <italic>BRCA1 </italic>185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals</article-title><source>Nat Genet</source><year>1995</year><volume>11</volume><fpage>198</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">7550349</pub-id><pub-id pub-id-type="doi">10.1038/ng1095-198</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Schaffner</surname><given-names>SF</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>JM</given-names></name><name><surname>Roy</surname><given-names>J</given-names></name><name><surname>Blumenstiel</surname><given-names>B</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>DeFelice</surname><given-names>M</given-names></name><name><surname>Lochner</surname><given-names>A</given-names></name><name><surname>Faggart</surname><given-names>M</given-names></name><name><surname>Liu-Cordero</surname><given-names>SN</given-names></name><name><surname>Rotimi</surname><given-names>C</given-names></name><name><surname>Adeyemo</surname><given-names>A</given-names></name><name><surname>Cooper</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>R</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>The structure of haplotype blocks in the human genome</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>2225</fpage><lpage>2229</lpage><pub-id pub-id-type="pmid">12029063</pub-id><pub-id pub-id-type="doi">10.1126/science.1069424</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Eberle</surname><given-names>MA</given-names></name><name><surname>Rieder</surname><given-names>MJ</given-names></name><name><surname>Yi</surname><given-names>Q</given-names></name><name><surname>Kruglyak</surname><given-names>L</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name></person-group><article-title>Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium</article-title><source>Am J Hum Genet</source><year>2004</year><volume>74</volume><fpage>106</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">14681826</pub-id><pub-id pub-id-type="doi">10.1086/381000</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnen</surname><given-names>PE</given-names></name><name><surname>Wang</surname><given-names>PJ</given-names></name><name><surname>Kimmel</surname><given-names>M</given-names></name><name><surname>Chakraborty</surname><given-names>R</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name></person-group><article-title>Haplotype and linkage disequilibrium architecture for human cancer-associated genes</article-title><source>Genome Res</source><year>2002</year><volume>12</volume><fpage>1846</fpage><lpage>1853</lpage><pub-id pub-id-type="pmid">12466288</pub-id><pub-id pub-id-type="doi">10.1101/gr.483802</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XD</given-names></name><name><surname>Barker</surname><given-names>DF</given-names></name></person-group><article-title>Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning <italic>RNU2-BRCA1</italic></article-title><source>Am J Hum Genet</source><year>1999</year><volume>64</volume><fpage>1427</fpage><lpage>1439</lpage><pub-id pub-id-type="pmid">10205276</pub-id><pub-id pub-id-type="doi">10.1086/302358</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>ML</given-names></name><name><surname>Penney</surname><given-names>KL</given-names></name><name><surname>Stram</surname><given-names>DO</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>McKean-Cowdin</surname><given-names>R</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name></person-group><article-title>A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>7516</fpage><lpage>7522</lpage><pub-id pub-id-type="pmid">16103107</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0132</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kidd</surname><given-names>JR</given-names></name><name><surname>Speed</surname><given-names>WC</given-names></name><name><surname>Pakstis</surname><given-names>AJ</given-names></name><name><surname>Kidd</surname><given-names>KK</given-names></name></person-group><article-title>A 100 kb block encompassing BRCA1</article-title><source>Am J Hum Genet</source><year>2003</year><volume>73</volume><fpage>173</fpage></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Rowe</surname><given-names>WL</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Buetow</surname><given-names>KH</given-names></name></person-group><article-title>Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations</article-title><source>Am J Hum Genet</source><year>2003</year><volume>73</volume><fpage>1073</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">14560401</pub-id><pub-id pub-id-type="doi">10.1086/379154</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>JK</given-names></name><name><surname>Przeworski</surname><given-names>M</given-names></name></person-group><article-title>Linkage disequilibrium in humans: models and data</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11410837</pub-id><pub-id pub-id-type="doi">10.1086/321275</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name></person-group><article-title>A DNA polymorphism discovery resource for research on human genetic variation</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>1229</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">9872978</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>JL</given-names></name><name><surname>Velazquez</surname><given-names>IA</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Greene</surname><given-names>MH</given-names></name></person-group><article-title>Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of <italic>BRCA1 </italic>mutation carriers</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><fpage>8629</fpage><lpage>8635</lpage><pub-id pub-id-type="pmid">16314625</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2005.02.9199</pub-id></citation></ref><ref id="B37"><citation citation-type="other"><article-title>National Laboratory for the Genetics of Israeli Populations at Tel-Aviv University</article-title><ext-link ext-link-type="uri" xlink:href="http://www.tau.ac.il/medicine/NLGIP/nlgip.htm"/></citation></ref><ref id="B38"><citation citation-type="other"><article-title>Environmental Genome Project, University of Washington</article-title><ext-link ext-link-type="uri" xlink:href="http://egp.gs.washington.edu/data/brca1/"/></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Yelensky</surname><given-names>R</given-names></name><name><surname>Pe'er</surname><given-names>I</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>Efficiency and power in genetic association studies</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>1217</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">16244653</pub-id><pub-id pub-id-type="doi">10.1038/ng1669</pub-id></citation></ref><ref id="B40"><citation citation-type="other"><article-title>POPGENE: the user-friendly shareware for population genetic analysis</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ualberta.ca/~fyeh/index.htm"/></citation></ref><ref id="B41"><citation citation-type="other"><article-title>SNPHAP: a program for estimating frequencies of large haplotypes of SNPs</article-title><ext-link ext-link-type="uri" xlink:href="http://www-gene.cimr.cam.ac.uk/clayton/software/snphap.txt"/></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Rowe</surname><given-names>WL</given-names></name><name><surname>Struewing</surname><given-names>JP</given-names></name><name><surname>Buetow</surname><given-names>KH</given-names></name></person-group><article-title>HapScope: a software system for automated and visual analysis of functionally annotated haplotypes</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>5213</fpage><lpage>5221</lpage><pub-id pub-id-type="pmid">12466546</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkf654</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15297300</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>BS</given-names></name></person-group><article-title>Inferences about linkage disequilibrium</article-title><source>Biometrics</source><year>1979</year><volume>35</volume><fpage>235</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">497335</pub-id><pub-id pub-id-type="doi">10.2307/2529947</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maniatis</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>CF</given-names></name><name><surname>McCarthy</surname><given-names>LC</given-names></name><name><surname>Hewett</surname><given-names>DR</given-names></name><name><surname>Tapper</surname><given-names>W</given-names></name><name><surname>Ennis</surname><given-names>S</given-names></name><name><surname>Ke</surname><given-names>X</given-names></name><name><surname>Morton</surname><given-names>NE</given-names></name></person-group><article-title>The first linkage disequilibrium (LD) maps: delineation of hot and cold blocks by diplotype analysis</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>2228</fpage><lpage>2233</lpage><pub-id pub-id-type="pmid">11842208</pub-id><pub-id pub-id-type="doi">10.1073/pnas.042680999</pub-id></citation></ref><ref id="B46"><citation citation-type="other"><article-title>EpiInfo Version 3.4.1</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/epiinfo/"/></citation></ref></ref-list></back></article> 